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The current key goals of the Thermal Infrared Imaging (TIRI) research community are; 
exploiting its potential as a clinical tool, spreading awareness of the increased capability 
of TIRI technology, and encouraging medical practitioners to apply and develop TIRI in 
real clinical settings. The United States Department of Defence, the main developers and 
custodians of TIRI technology, recently conducted a technology transfer study to 
identify the major challenges that must be met for adopting TIRI as a clinical tool. The 
identified challenges include: (1) Developing objective protocols for clinical data 
acquisition, (2) Developing methods for useful quantitative interpretation of clinical 
TIRI data, and (3) Exploring the potential for pathophysiological aetiology of thermal 
signatures (Diakides, 2013). This thesis makes an integrated contribution to overcome 
the identified major challenges. 
This work makes significant contributions towards transforming thermal 
infrared imaging into a reliable medical diagnostic tool through: 1) Development of 
clinical TIRI protocols; 2) Application and validation of the developed protocols through 
a clinical study; 3) Quantitative analysis of the thermographic data; and 4) Exploitation 
of the acquired data for determining the heat source depth using a recently developed 
mathematical model. 
 For conducting a series of interconnected investigations, this work began by 
objective characterization of the fundamental architecture of a clinical TIRI system with 
a view to facilitation of imaging protocol development, elucidation of the mechanism of 
human thermal infrared emittance and validation of TIRI as a diagnostic tool. A 
database of over 500 thermal infrared, magnetic resonance and scintigraphic images 
was developed for demonstrating the potential of intra and inter human tissue 
discrimination on the basis of thermographic data. The acquired TIR images were 
employed to investigate if the assumptions of universal grey-body emissivity and 
transmission of heat from subsurface tissue layers, as employed in heat transfer 
models, are acceptable for deploying TIRI in clinical investigations. Finally, using the 
acquired thermographic data, an attempt was made to determine the heat source depth 
in biological tissues for discriminating between healthy and unhealthy tissues. This step 
also helped in validating a newly proposed graphical method of determining depth of 
abnormal heat source in human body. 
 Unlike any of the previous works in this field, these interconnected studies, 
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BACKGROUND AND INTRODUCTION 
This chapter outlines the developmental history of medical TIRI, and describes how 
the field has evolved from the first experimentation in the late 1950’s, into its current 
state within the demanding world of evidence-based medicine. The chapter also 
presents the key challenges in making medical TIRI viable, and translates these key 
challenges into the problem definitions motivating this work. The chapter presents a 
plausible  way to approach the identified  problems, both as isolated challenges and as 
an integrated program of research. Finally, this chapter defines research objectives and 
describe contributions that were made to the field in the reaching of those objectives. 
 
1. Background 
1.1 Developmental History of Medical TIRI  
Thermal infrared imaging (TIRI) is a technique in which heat-sensitive cameras 
produce images of temperature distribution across object surfaces. Because 
temperature distributions across human skin can give valuable insight to underlying 
physiological processes, and because TIRI is a non-contact, non-ionising technique, it 
has great potential as a diagnostic tool for clinical medicine and biometrics. The 
medical usefulness of tissue temperature information has been recognized since the 
days of Hippocrates ~400 BC, and medical TIRI is one of the latest in a long line of 
techniques designed to conveniently acquire this temperature information, and 
communicate it to physicians in a way that can helpfully guide their treatment 
decisions. 
The earliest recorded explicitly medical use of TIRI occurred in 1959, when 
Francis Ring used a modified version of a prototype military TIRI camera called the 
‘Pyroscan’ to create the first medical TIRI at Middlesex Hospital in London, Figure 1-1. 





medical applications, with the ability to acquire far better clinical images. The 
Pyroscan 2 had a slow mechanical scanning process that meant it took around five 
minutes to record a single image, and the final images were written line by line on 
electro-sensitive paper.  In 1964, British surgeon K. Lloyd Williams showed that many 
tumours are hotter than their surrounding healthy tissues, and that the hotter the 
tumour, the worse the prognosis for the patient. This phenomenon of tumours as focal 
heat sources is now better understood and attributed to specific physiological 
mechanisms known as the ‘Warburg Effect’ and hyperactive ‘angiogenesis’ (Ring & 
Ammer, 2012; Arthur & Khan, 2011d, 2013). By the mid 60’s, the images were 
displayed on a cathode-ray screen in black and white. Image processing by computer 
had not yet arrived so much discussion was given to schemes to score the images 
 
 
Figure 1-1. Left - The prototype ‘Pyroscan’ TIRI system, made for military applications in 1942, 
and Right - the first medical TIRI image revealing the obvious difference in appearance of the 





subjectively, and to look for hot spots and asymmetry of temperature in the breast. 
Generation of false colour TIRI’s was only possible by photography at this time, with a 
series of bright isotherms being Manually ranged across the temperature span of the 
image, each being exposed through a different colour filter and superimposed on a 
single frame of film (Ring & Ammer, 2012). By the mid 60’s, the images were displayed 
on a cathode-ray screen in black and white. Computational image processing was not 
possible so discussions remained focused on  the schemes to score the images 
subjectively, and on  looking for hot spots and asymmetry of temperature in the breast. 
Generation of false colour TIRI’s was only possible by photography at this time, with a 








Figure 1-2. ‘Pyroscan 2’, the first Medical TIRI system. Middlesex Hospital UK, 1962. 
image, each being exposed through a different colour filter and superimposed on a 
single frame of film (Ring & Ammer, 2012).  
In Bath England, a medical imaging system originally developed for nuclear 
medicine in Sweden was adapted for medical TIRI, Figure 1-2. A colour screen was 
provided to display the digitised image, allowing selection of standard regions of 
interest, and approximate quantitative measurements of absolute skin temperature 
image, each being exposed through a different colour filter and superimposed on a 
from images obtained.  In applied TIRI, our ability to make quantitative analyses is 
limited by how well we understand the emissivity behaviour of the object of interest – 
in medical TIRI we are nearly always concerned with the emissivity behaviour of 
human skin. Earlier work by the American physiologist J. Hardy in 1939 suggested that 
human skin is a highly efficient thermal radiator with an emissivity around 0.98, which 
is close to that of a perfect black body. Despite this high emissivity, the TIRI technology 
that was available in the early 1970’s struggled to detect the intensity levels of 
emittance that radiate from human skin regions, which at average temperatures 
around 34°C is about 495 W/m2 at peak frequency (~9.5μm), from areas of skin 
significantly smaller than 1 m2 (Arthur & Khan, 2011d, 2013). 
In the early 1970’s, a cancer-driven surge of research interest led to several 
medical TIRI research centres emerging across Europe, the United States, and Japan 
(Ring & Ammer, 2012). Awareness that physiological mechanisms like the Warburg 
Effect and cancerous angiogenesis make regions of cancerous cells significantly hotter 
than healthy neighbouring cells, meant oncology was identified as an area of great 
promise for TIRI to contribute. Hopes that TIRI would revolutionise breast cancer 
screening provided the impetus for development of more sensitive TIR detectors, 
Figure 1-3.   
In 1974 the European Thermographic Association was formed, with a charter to 
form guidelines for good practice in medical TIRI, and an inaugural conference in 
Amsterdam (Diakides et al., 2007). These guidelines were to include requirements for 





imaging in medicine and pharmacology. Release of these guidelines resulted in a 
recommended lexicon of clinical TIRI terms (Aarts, 1978), suggestions that optics and 
human skin emissivity should be investigated in greater detail as influential sources of 
thermometric error (Salter, 1976; Clark, 1976; Watmough, 1977), and some expert 
opinion-based recommendations for TIRI procedure in specific context of locomotor 
disease (Engel, 1979).  
The early 80’s saw more expert opinion recommendations for general image 
acquisition and analysis practices (Ring, 1983; Engel, 1984), and a guideline for 
analysis of TIRI’s based on anatomic asymmetries was released by the American 
Academy of Thermology in 1986. The trajectory of the field of medical TIRI through 
the late 70’s and all of the 80’s was primarily driven by the market forces surrounding 
TIRI detector technology, Figure 1-3. The technical challenges that dictate the rate of 




Figure 1-3. History of the development of infrared detectors and systems. Three generations of 





systems), 2nd Gen (staring systems – electronically scanned), and 3rd Gen (multicolour 
functionality and other on-chip functions) - (Rogalski, 2012). 
IR detectors - Figure 1-3 (Rogalski, 2011). As it turned out, these market forces only 
recently allowed us to overcome the technical challenges that have hitherto prevented 
critical mass in biomedically-directed TIRI research (Diakides, Diakides, Lupo, Paul, & 
Balcerak, 2007).Specifically, the vast majority of 20th century TIRI research revolved 
around ‘quantum detectors’, i.e. detectors whose faculty for IR transduction comes 
from their propensity to exhibit photonic/quantum (as opposed to ‘thermal’, or other 
types of) physical phenomena. It should also be noted that this research was almost 
exclusively conducted by groups within the military, or in high-end industrial research 
laboratories that were funded by military programs.  
Most groups pursued development of quantum-based TIRI because it was 
already a proven (although not necessarily ideal or elegant) technology, whereas 
thermal-type IR detectors required an unknown amount of research and development 
before acceptable sensitivity and response time performance would be achieved 
(Rogalski, 2012). However, as quantum detectors require cooling to prevent thermal 
generation of charge carriers from rendering their output signals unusably noisy, it is 
necessary to incorporate a cooling system into any quantum TIRI camera. This cooling 
functionality was/is best achieved by incorporation of components called ‘Sterling 
cycle coolers’ into TIRI cameras. As these cooling systems are significantly costly (not 
to mention bulky and heavy) and rarely last beyond 10,000 operating hours; hitherto, 
the only available TIRI systems with sufficiently well-developed performance for 
practical applications were prohibitively expensive for many would-be researchers 
(Rogalski, 2012). This prohibitive cost formed a barrier to entry for many new (i.e. 
non-military) promising fields of applied TIRI research, including us in biomedical 
(Ring & Ammer, 2012; Arthur & Khan, 2011d, 2013). 
Of the relatively few research programs that did pursue uncooled (i.e. thermal 
detector-based) TIRI, it was those funded by the United States military that yielded the 
game-changing technology of vanadium oxide (VOx) bolometers (Rogalski, 2012). The 





for the field of medical TIRI (Figure 1-4), allowing free industry to finally exert its 
powers of vertical integration and scale economy to produce a practical TIRI system 
with both research-worthy performance and accessible cost, removing the foregoing 
barrier to entry into biomedical TIRI research – see point 1990 in Figure 1-3. With 
subsequent advances in large-scale integration, micromachining, semiconductor 
technology and optics, the broader civilian research community now has access to 
high-quality low-cost TIRI systems, and excellent prospects of achieving critical mass 
in clinically-directed research (Arthur & Khan, 2011d, 2013). The newfound 
accessibility of TIRI technology in the early 90’s caused a huge increase in the number 
of civilian TIRI camera owners, which in turn raised awareness of the general 
improvements in TIRI capability (speed, thermal sensitivity, spatial resolution) that 
had been made since the previous evaluation of TIRI for medicine that occurred in the 
late 70’s, (Figure 1-3). The consensus that it was time to re-evaluate the utility 
potential of TIRI in medical applications led organisers of the 1996 IEEE EMBS 
conference to release a CD-ROM of seminal papers on medical TIRI. This CD was 
sponsored by the U.S. Office of Technology Applications and the U.S. National 
Technology Transfer Centre, and is available on request from the Medical Imaging 








Figure 1-4. MedLine literature trending for appearance of ‘Thermal Infrared Imaging in 
Medicine’, in scholarly biomedical publications normalised by word count per year. Highlighted 
inflection points correspond to the first medical TIRI by Francis Ring in 1959, and the 
declassification of VOx bolometer technology in 1992 that made TIRI accessible.  
This collection of papers emphasised the persisting need for development of objective 
image acquisition protocols, and development and demonstration of quantitative 
analytical techniques (Clark & Calcina-Goff, 1996). In 2001, the Glamorgan group 
launched a project to compile a database of healthy temperature profiles for all parts of 
the human body, which has since proven that standardised FOV’s (fields of view) and 
ROI’s (regions of interest) vastly increase the reproducibility of healthy clinical TIRI 
profiles (Ammer, 2001). Also in 2001, the US DOD held an important technology 
transfer workshop called "Tanks to Tumors" in Arlington, Virginia (Paul, 2002). The 
workshop was co-sponsored by the Office of the Director, Defense Research and 
Engineering, Space and Sensor Technology Directorate; the Deputy Assistant Secretary 
of the Army for Environment, Safety and Occupational Health; the Defense Advanced 
Research Projects Agency; and the Army Research Office. The purpose was to explore 
technological opportunities for integration of image processing, Web-based database 
management and development, and infrared sensor technology for the early detection 
of breast cancer (Paul, 2002).  
The ‘Tanks to Tumors’ workshop was motivated by significant military 
advances in TIRI and automatic target recognition coupled with the medical 
understanding of abnormal vascularity (angiogenesis) offering the prospect of 
automated detection from one to two years earlier than other, more costly and 
invasive breast cancer screening methods. It was here that objective clinical image 
acquisition protocols, improved quantification ability through further understanding 
of skin emissivity, and case study demonstrations of successful pathological aetiology – 
were again identified as priority focus areas for ongoing research (Paul, 2002; 
Diakides, 2013).   
In 2010, the IEEE EMBS chose ‘Considerations for developers of new thermal 
imaging technologies’ as the theme for the workshop on ‘Lessons Learned from Medical 





supporting thermal surgery guidance in the fight against cancer alone provides 
sufficiently compelling motivation for development of clinical thermal imaging 
technologies, image-guided thermal therapies are increasingly being used to also treat 
benign disease in the heart, liver, kidney, lung, prostate, brain, bone, uterus and other 
organs (Haemmerich & Laeseke, 2005). Moreover, transferrable applied research 
directed toward general advancement of insightful human thermal infrared imaging 
capability is of great interest to researchers in fields outside thermal therapies, 
including; affective computing (M. Khan, Ingleby, & Ward, 2006), diagnostic medical 
imaging (Çetingül & Herman, 2010b; de Weerd, 2010a), and human identification at 
distance (DARPA, 2000-2003; L. B. Wolff, Socolinsky, & Eveland, 2005). Current 
approaches to human TIRI can be broadly described as either ‘classification’, or 
‘bioheat inversion’.  
The classification approach involves the use of human TIRI data to train robust 
classifiers for specific pattern recognition applications, within fields such as: affective 
computing (M. Khan et al., 2006; M. Khan, Ward, & Ingleby, 2009; Pavlidis et al., 2012), 
human identification at distance (DARPA, 2000-2003; L. B. Wolff et al., 2005), and 
diagnostic decision support (Çetingül & Herman, 2010c; de Weerd, 2010b). The 
classification approach has yielded several effective expert systems, with both 
classification robustness and specificity limitations stemming from the inherent spatial 
and convolutional abstraction layers (M. Khan et al., 2006; M. Khan, Ward, & Ingleby, 
2009; Diakides et al., 2007; Wilson & Spence, 1988). The inherent nature of their 
intended operating environments means these pattern-recognising classifiers cannot 
rely on controlled image acquisition conditions and subject preparation protocols. 
Although absolute quantification of calibrated image content can give enhanced 
classifier performance and robustness, their principal function of spatial feature 
recognition means relative contrast with neighbouring pixels is more important (M. 
Khan et al., 2006; M. Khan, Ward, & Ingleby, 2009).  
The bioheat inversion approach to human TIRI (detailed further below) 
requires development and use of bioheat transfer models, geometric models of 
anatomic milieu, and high fidelity inference and representation of several parameters. 





existing TIRI-compatible bioheat transfer models being Ill-posed, and excessively 
complex for analytical solution (Arthur & Khan, 2011d, 2013; Izhar & Petrou, 2012; Liu 
& Deng, 2009). In these bioheat transfer modeling approaches, quantification and 
absolute thermometric calibration is of fundamental importance. Efforts to date have 
not explored involvement of a complimentary thermal imaging modality (e.g. MRI) to 
enable joint inversion (Arthur & Khan, 2011d, 2013). Ability for quantification in 
applied TIRI critically depends on accuracy of characterization of emissivity behaviour 
of the imaged object’s surface, which in the case of clinical TIRI and human skin 
presents significant room for improvement (Arthur & Khan, 2011d, 2013). 
1.2 Problem Definition 
As the goal of this project is to make a strategic contribution to the advancement of 
TIRI for clinical applications, the problem can be defined in terms of the challenges 
that must be overcome in order to achieve that goal. To recap, in 2001 the U.S. D.O.D. 
(the historical primary developers and custodians of TIRI technology) studied how to 
best approach the transfer of TIRI technology from military to medical applications 
(Paul, 2002). This study agreed with the consensus in the scholarly literature, 
identifying development of objective clinical image acquisition protocols, improved 
quantification ability, and demonstrations of successful pathological etiology as 
priority areas for focus of ongoing research efforts toward advancement of TIRI for 
medical applications. 
The first aspect of the problem can be described as the lack of an organised 
systems architecture platform from which researchers can manageably and 
consistently develop protocols. To date, the published material that offers guidance for 
design and execution of new applied clinical TIRI research programs consists of expert 
opinion pieces, without visibility to the underlying physical, physiological, and optical 
considerations that led to the recommendations given. Moreover, the majority of this 
content is relatively high level, despite being given in context of specific disease states 
and anatomic locations. Decisions to set key experimental parameters (optical 





absolute values are often reported, but not accompanied by rationale or derivation 
from first principals – e.g. optical, physical, or physiological. This incompleteness of 
information has historically made it difficult for new researchers to decide how much 
of a given procedural recommendation is relevant or applicable to their envisaged 
application, and forces each experimental design from scratch.  
This lack of a common science-driven starting point has led to a field of 
disparate studies, which hinders cross pollination of findings and progress. A possible 
reason that the field has evolved without this platform to date, is that in context of 
medical imaging technology, TIRI experiments are particularly challenging to design 
for control of functional variables as everything in the clinical setting is a source of 
potentially confounding TIR noise – i.e. everything in the clinical setting emits TIR 
radiation with similar wave properties to the subject of interest (human body), 
whereas the MRI coil, X-Ray tube, or ultrasound emitter are typically the only sources 
of the functional signal in an established radiographic suite. In the same way that 
effective design of an MRI suite is impossible without a comprehensive layout diagram 
showing functional characterisation of everything ferrous / magnetic in the vicinity, 
the absence of such a starting point for TIRI research designers has resulted in a field 
of inconsistent investigations with unknown levels of objectivity, and no common 
ground from which to discuss development of ‘gold standard’ practices, as enjoyed by 
researchers working in the established medical imaging modalities. 
The second aspect of the problem, which follows directly from the first, is the 
lack of literature detailing examples of clinical TIRI protocol implementation. Detailed 
written accounts of how clinical protocols have been implemented in context of 
specific pathologies and patient populations serve 2 crucial purposes, 1) instil elevated 
levels of medical community acceptance of the technology by demonstrating that tests 
of TIRI’s efficacy can be put into practice in compliance with accepted clinical trial 
standards for validity and reliability, and 2) provide a documented account of all 
lessons learnt and mistakes made, from which all subsequent investigators can learn 
and benefit when designing experiments and studies for further progress in the field. 
The third aspect of the problem is centred on challenges to quantification of 





predominantly driven and limited by how accurately the emissivity behaviour of the 
target body is understood. In the case of clinical TIRI, the emissivity behaviour of 
interest is that of human skin, which has historically been approximated at a constant 
value of 0.98 irrespective of anatomic location or any other variable factors. Moreover, 
these doubts surrounding quantification ability will not be resolved until clinically 
useful quantitative analysis have been demonstrated. The problem can therefore be 
described as a lack of accounts of validated quantitative analyses of clinical TIRI data 
that yield clinically useful information.  
To summarise, the problem to be addressed by this thesis work may be defined 
in terms of the 3 major challenges to the advancement of TIRI for clinical applications, 
namely: lack of an organised and standardised clinical TIRI systems architecture from 
which researchers can manageably and consistently develop protocols, lack of 
literature documenting learnings gained through development and application of 
pathology-specific and anatomy-specific protocols, and insufficient understanding of 
human skin emissivity for quantitative aetiological analyses of clinical TIRI data 
obtained. 
1.3 Approach and Rationale 
As described in the previous section, the key challenges facing advancement of medical 
TIRI can be defined as a set of discrete but intrinsically related sub-problems. 
Accordingly, this doctoral program of research was designed as an integrated series of 
related phases of work. The most logical order in which to approach these sub-
problems naturally emerges from their intrinsic relationships with each other, with 
completion of one phase prerequisite for commencement of another. Specifically, logic 
dictated addressing the sub-problems in the following order: systems architecture 
definition, protocol design, protocol application, and quantitative analysis (flow 
diagram below).  
Mapping out an organised architecture for the clinical TIRI system was the logical first 
step, because prerequisite for objective design of clinical protocols. Similarly, protocol 





collection) was prerequisite for quantitative data analysis (Arthur & Khan, 2011d). 
This sequential and integrated approach gave the added benefit of showing 
subsequent designers of clinical TIRI research programs a complete end-to-end 
example of how the various components flow into each other through the life cycle of a 
clinical TIRI research program.  
Approaching the overall program of work as a sequence of discrete phases, 
made it possible to adopt a tailored approach to each individual phase that was best 
suited to the tasks involved. The goal of the first phase was to systematically map out 
and organise the architecture of the generic clinical TIRI system, to create a detailed 
and standardised platform from which clinical TIRI protocols can be developed. This 
first phase of the work was approached in the same way as a systems architecture 
project for a complex engineering system, starting with functional definition of the 
overall high-level systems architecture, then going into progressive levels of detail to 
describe the salient functional aspects of the various subsystems involved, and their 
functional (thermal / infrared) interactions with each other. Using this approach, the 
primary subsystems of the clinical TIRI system (namely: TIRI camera, human tissue 
volume, and ambient clinical atmosphere) and their interactions with each other were 
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The second phase of work, designing clinical protocols, was approached in the same 
manner as one would investigate a new indication of an established radiological 
modality. This first involved literature review of the system’s architecture in 
consultation with collaborating medical professionals to select a pathological context 
that would feature sufficient thermophysiological manifestation at a sufficiently 
superficial and thermodynamically homogenous anatomic location to warrant 
investigation by TIRI. Once tibial stress pathology had been identified, a similar 
exhaustive exercise was performed to identify a domestic Australian patient 
population that featured both a sufficiently high incidence of tibial stress pathology, 
and a controlled operating environment conducive to a longitudinal clinical study.  
Once the Australian Army basic trainee population had been identified, it was 
then possible to identify a population-representative cadaver for deep thermodynamic 
characterisation of the anatomic context (the pretibial tissue volume) as would be 
done prior to investigation of a new indication in an established modality like MRI or 
X-Ray. Identification of the patient population also made it possible to extract the 
salient population-representative ergonomics (body dimensions) required to design 
the optical configuration for clinical data collection (average tibial dimensions drive 
lens-ROI distance, which in turn drives design of gantry and spatial resolution at the 
ROI surface (Arthur & Khan, 2011d, 2013).  
The goal of the third phase of work was to apply the clinical protocols 
previously developed to evaluate their efficacy, highlight areas for possible 
improvement, and collect real clinical TIRI data under known controlled conditions for 
subsequent quantitative analyses. The approach to this logistical phase of work was 
extremely structured, and involved evaluation of TIRI against the already laid out 
ethical compliance practices normally applied to more established medical 
technologies. Although this phase of work was extremely applied, obtaining approval 
from both Curtin University and the Australian Defence Force, and implementing a 
three month clinical trial at a military hospital proved extremely valuable as both a 
learning exercise and demonstration of the seriousness of clinical TIRI research.  
In order to capture the full value of this protocol application / clinical study phase as a 





through the processes required for registered with both the WHO (World Health 
Organisation) and the ANZCTR (Australia New Zealand Clinical Trials registry). Clinical 
trial registry details are included in appendices. A full report of the trial’s protocol, 
implementation, and early results was presented at the IEEE EMBC 2011, and 
published in proceedings which are available online. The goal of the fourth phase of 
work was to use the TIRI data collected during the previous clinical study to 
demonstrate a quantitative analysis with significant and obvious clinical utility. The 
thermophysiological concepts of the Warburg effect and oncological angiogenesis 
mean cancerous tumours are well known sources of abnormally focal heat.  
Given the widespread use of tumour depth as a critical predictive factor for: 
staging of primary malignancy, the nature and degree of metastasis, appropriateness of 
resection, probability of upstaging, tumour control performance and general 
prognosis, combined with the high promise of successful TIRI-based heat source depth 
determination given by similar studies on tissue phantoms (Wang et al), it was decided 
to approach this phase of the work as an exercise in TIRI-based heat source depth 
determination, or ‘HSDD’. This analytical phase of work was approached as one would 
approach a new indication with an established medical imaging modality, utilising 
HSDD via cadaveric dissection and MRI as the ‘gold standard’ validation techniques. 
This approach proved extremely successful, yielding some extremely encouraging 
results that successfully demonstrated a quantitative analysis of TIRI data with 
obvious clinical utility. Going through this phase of work toward advanced 
quantification prompted a supplementary investigation directed toward advanced 
characterisation of human skin emissivity, known to the be single most important 
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Having identified understanding of emissivity behaviour as the key factor determining 
quantification ability, the goal of this supplementary phase was to advance the current 
understanding of human skin emissivity behaviour, with a view to improved scope for 
quantitative deconvolution of human TIRI data, as found to be necessary during the 
HSDD phase of work. This phase was approached as a technical material 
characterisation study, and was accordingly conducted in collaboration with leading 
technical research staff from FLIR Systems Australia, at the FLIR Systems Calibration 
Laboratory in Melbourne, Victoria. The study was approached as any other emissivity 
behaviour characterisation study, observing the highest standards in blackbody 
radiometric calibration and atmospheric control, at the nation’s leading dedicated TIRI 
camera calibration facility. This rigorous material characterisation approach was 
extremely successful, yielding interesting results which constituted the desired 
advanced understanding of human skin emissivity behaviour, which have since been 
published in the IEEE Journal of Biomedical and Health Informatics (Arthur & Khan, 
2013). For completeness, this section also introduces the idea of thermometric MRI as 
a complimentary medical imaging modality for validation of clinical TIRI and inversion 
of TIRI-compatible bioheat transfer models. The author feels thermometric MRI should 
be a focus of ongoing work in advancement of clinical TIRI. 
1.4 Objectives & Contributions 
The following four items describe the specific objectives of this program of research 
work: 
1. To objectively and systematically map out the architecture of the generic 
clinical TIRI setting as a controllable system, and define an organised meta-level 
system architecture, including salient TIR functional characterisation of both 





Development and presentation of this systems architecture should be optimised 
for use as a helpful starting point for designers of clinical TIRI protocols and 
engineering solutions for experimental control measures. 
2. Design objective protocols for acquisition of clinical TIRI data, demonstrating 
efforts to control all functional TIR variables as defined in the aforementioned 
systems architecture, and foster conditions for optimal data acquisition. These 
protocols should be developed in the context of a specific pathology, anatomic 
location, and patient demographic. The pathology and sample demographics 
should be chosen in careful consideration of conducive thermophysiology, 
known strengths and limitations of TIRI, and pragmatic realities of clinical 
study implementation (Arthur & Khan, 2011d, 2011e; Arthur, Khan, & Barclay, 
2011a, 2011b). 
3. Conduct a longitudinal clinical study to field-test the clinical protocols that have 
been developed, and to acquire clinical TIRI data for subsequent quantitative 
analysis. This clinical study should allow for evaluation and documentation of 
the efficacy of the clinical protocols, in terms of epidemiological consistency, 
specificity, temporality, and reversibility of the data obtained. The data 
obtained should be of a nature conducive to subsequent quantitative analyses, 
and also shed light on utility potential of TIRI in clinical management of the 
chosen pathology (Arthur & Khan, 2011d, 2011e; Arthur, Khan, & Barclay, 
2011a, 2011b). 
4. Carry out related quantitative analyses to: 
a) rigorously characterise human skin emissivity behaviour to evaluate the 
relative validity of the two conflicting bioheat transfer models conventionally 
used for interpretation of human TIRI data, namely; global greybody emissivity, 






b) demonstrate how clinically-useful TIRI-based measurements of skin 
temperature can lead to heat source depth determination (HSDD). 
5. Examine if the acquired thermographic data would help in distinguishing 
between the normal and abnormal human tissue heat source depths or shape 
factors. 
 
Each of the five objectives described above was successfully achieved, and in doing so, 
the following key contributions were made to the field of medical TIRI: 
1. Developed objective protocols for clinical TIRI that guide consistent and 
standardised acquisition of high quality medical TIRI data; 
2. Gained and published new and novel insight to the utility potential of TIRI in 
clinical management of osseous stress pathology. 
3. Discovered and published an advanced understanding of human skin’s 
emissivity behaviour that enables improved quantitative interpretation of 
clinical TIRI data. 
4. Employed and validated an elegant technique for quantitatively determining 
the heat source depth (HSDD) from real clinical TIRI data, with several 
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THEORY OF CLINICAL THERMAL INFRARED IMAGING 
Chapter Summary 
This section provides a technical explanation of the thermal infrared imaging (TIRI) 
process, highlighting salient idiosyncrasies of using TIRI for diagnosing human 
conditions in a clinical setting. The TIRI process flow is described in terms of the 
following stages: thermo-active disease state; thermo-physiological process; radiative 
emission via the ‘thermal’ mechanism; infrared propagation; infrared detection; and 
quantitative interpretation.      
 
Thermal Infrared Imaging 
1.1 Thermophysiology 
The premise for clinical utility of TIRI rests on subsurface tissue conditions 
manifesting themselves as characteristic temperature distributions across the skin’s 
surface, via thermophysiological mechanisms like those in Table 0-1. As the human 
body generates heat via catabolism and muscle contraction, and blood is the primary 
medium of heat transfer within the body, disease states indicated for TIRI 
consideration must feature physiological mechanisms that modulate superficial 
perfusion and/or catabolism (Anbar 1998; de Weerd, 2010b).  
The four main types of thermo-physiological mechanisms featured in the 
medical TIRI literature are vascular interruption, neurogenic vascular dysfunction, 
pathological nitric oxide production, and hypercatabolism (Table 0-1) (Arthur et al., 
2011b; Çetingül & Herman, 2010a; Hooshmand, Hashmi, & Phillips, 2001; Swann & 






Table 0-1 Physiological Mechanisms of TIRI-applicable Thermal Aberration. 






























Complex regional pain, 
Cancers,  
Glaucoma, Heat burns.  
Chemical nerve irritation, 
Systemic disorders of the 


































*Pathology list not exhaustive – limited to those reported in the clinical TIRI literature. 
vasculature create foci of thermal contrast via; embolism, aneurysm, reactive 
hyperaemia and ischemia, angiogenesis, and haematoma following haemorrhage 
(Baglin, Crocker, Timmins, Chandler, & Boughton, 1991; Emery, Flavin, Nissen, & 
Mooney, 1996; Falk, Walther, Philippi, Autschbach, & Krieger, 1995; Friedlander AH, 
1994; Garcia, Fernandez, Monge, & Gomez, 1996; Merin, Elami, & Zucker, 1995; 
Okudera, Kobasyashi, & Toriyama, 1994; Santori, Vitullo, Stopponi, Santori, & Ghera, 
1994; Wheeler & Anderson, 1995).  
The neurogenic class of mechanisms which includes mechanical nerve damage, 
chemical nerve irritation, and systemic disorders of the central nervous system - can 
impair neural control of peripheral vascular tone leading to pathological 
vasoconstriction or vasodilation (Groeneweg, Niehof, Wesseldijk, Huygen, & Zijlstra, 
2008; Huh, Park, Ranson, Campbell, & Ravanbakht, 2009; Lang, Claus, & Handworker, 
1995; Pascoe, Herrick, & Purohit, 1997; Tkova et al., 2010; Wasner, 2010). Several of 
these pathologies feature focal hypercatabolism as a diagnostic feature, perhaps best 
represented in the medical TIRI literature by the “Warburg effect” describing the 
propensity of cancerous cells to hypercatabolise glucose into lactic acid and produce a 
localised region of heat (Mathupala, Rempel, & Pedersen, 1995; Mullen, 1994; Reeves, 
Bauer, Capra, Davies, & Battistutta, 2004; Wolf, Agnihotri, & Micallef, 2011).  
Various traumatic and infectious conditions are also known to feature TIRI –
relevant hypercatabolism, as are the more distributed dysfunctions of the endocrine 
system (Cuthbertson & Tilstone, 1969; Schindeler, McDonald, Bokkoa, & Little, 2008; 
Schoettler, 1986). In addition, several dysfunctional physiological processes result in 
hyper-production of nitric oxide (NO), which induces relaxation in the smooth muscles 
of the vasculature, promoting vasodilation and perfusion, and inhibiting 
vasoconstriction (Anbar, 1995; Anbar & Gratt, 1997; Campero, Verdugo, & Ochoa, 
1993; Fahi, Argiolas, Chiavarelli, & Del Basso, 1996; Garcia-Villalon, Garcia, Fernandez, 
Monge, & Gomez, 1996; Maigne, Treuil, & Chatellier, 1996; Takahashi, Takahashi, & 
Moriya, 1994). In summary, TIRI-detectable physiological mechanisms are a central 





1.2 Thermal Emission 
In medical TIRI, the phenomenon of thermal emission is what allows the thermal 
manifestation of the aforementioned pathophysiological processes to be detected by 
TIRI systems as spatial distributions of electromagnetic waves. Electromagnetic waves 
can be defined as self-propagating disturbances of perpendicular electric and magnetic 
fields, wherein both fields are perpendicular to the direction of propagation. The term 
‘electromagnetic radiation’ refers to the physical phenomena within bodies of matter 
that involve emission and propagation of these waves. The term ‘thermal radiation’ 
refers to the specific form of radiation in which the mechanism of emission is ‘thermal’, 
i.e. physically manifested by the translational kinetics of the emitting body’s 
constituent charged particles.  
To paraphrase, in every physical body, every atom and every molecule vibrates. 
The average kinetic energy of these vibrating particles is represented by the absolute 
temperature, described in units of Kelvin. According to the laws of electrodynamics a 
moving electric charge is associated with a variable electric field that produces an 
alternating magnetic field. This interaction is considered to produce electromagnetic 
waves that radiates from the body at the speed of light. The thermal radiation 
fundamental to medical TIRI is thus distinct from other forms of EMR that involve 
other emission mechanisms, such as synchrotron, maser, or Compton processes. 
 
 
Figure 0-1. Radiation: the emission and propagation of electromagnetic waves (Spring, Inoue, 





1.3 Infrared Propagation 
Having outlined the physiological processes that TIRI can detect, and the phenomenon 
of thermal emission that allows the resulting skin temperature distributions to leave 
the human body; this section describes how those surface temperature distributions 
pass from the site of thermal emission at the skin’s surface, to the medical TIRI system.  
The term ‘infrared radiation’ refers to EMR involving waves that propagate with 
wavelengths ranging from approximately 0.75 µm to 1000 µm, as shown in Figure 0-2. 
The etymology of the infrared stems from proximity to the wavelengths our human 
eyes perceive as ‘red’, with infra meaning beneath. As shown in Figure 0-2 the sub-
bands within the infrared band follow this nomenclature, with their exact upper and 
lower limits defined according to sensor response in subjective applications. As 
clinically relevant temperatures are well within the 1 - 1000K range (human surface 
euthermia ≈ 307 K) the associated thermal radiation will always involve infrared 
emittance.  
More specifically, spectral variations in power distribution from physical bodies 
at clinical temperatures (Figure 0-3), transmittance of the clinical atmosphere (Figure 
0-3 black), and sensitivity of available TIR detector technology - narrow our 
consideration to the MWIR (mid-wave infrared) and LWIR (long-wave infrared) sub-
bands (Arthur & Khan, 2011d).  Figure 0-3 illustrates the implications of conducting 
applied TIRI in this MWIR-LWIR spectrum, which translate to  
 
 





engineering considerations when designing clinical TIRI protocols. Chief among these 
considerations is the fact that the water content of the 5-8 µm region within ambient 
clinical atmospheres creates sufficiently low transmittance to infrared propagation 
that there is no point developing detectors with sensitivity in that band. 
As shown by the red curve passing through the 2-5 µm band, one must also 
consider how weakly the human body emits TIR radiation in the MWIR (0-25 Wm-2µm-
1). This weak emittance is somewhat offset by the impressive sensitivity achievable 
with MWIR detector materials, which must be considered in context of the extra cost 
and cooling requirements of MWIR TIRI systems. So in summary, the wave properties 
of human thermal emittance, and the wave transmitting properties of clinical 
atmospheric conditions, drive the design decisions for medical TIRI systems.  
 
 
Figure 0-3: Red curve showing a clinically-relevant spectral power distribution; Black curve 
showing spectral variation in atmospheric transmittance; Grey rectangle showing region of zero 
transmissivity due to absorption of emittance by molecules of water vapour (Arthur & Khan, 
2013). 
1.4 Infrared Detection 
Having described the physiological processes that TIRI can detect, and how the 





emission and infrared propagation; this section now describes the fundamental 
physics that allow medical TIRI systems to convert that infrared emittance into a 
diagnostically useful digital image.  
Several physical phenomena have been investigated for use in IR detection, 
most notably; impedance variation (bolometers), thermoelectric power 
(thermocouples), gas expansion (Golay cells), pyroelectricity (pyroelectric detectors), 
photon drag, the Josephson effect (Josephson junctions, SQUIDs), internal emission 
(PtSi Schottky barriers), fundamental absorption (intrinsic photodetectors), impurity 
absorption (extrinsic photodetectors), and low dimensional solid phenomena 
[superlattice, quantum well (QW) and quantum dot (QD) detectors] (Norton, 1999; 
Rogalski, 2012). Most IR detectors can be classified as either ‘thermal’ or ‘quantum’; 
depending on the physical phenomena they exploit to transduce IR emittance.  
In addition to certain performance and design implications for infrared imaging 
systems, the key functional difference between thermal and quantum  
 
Figure 0-4. Wavelength-dependence of quantum-type IR detector response to irradiance, in 
context of the wavelength-independence of thermal-type IR detector response.  
detectors is their relative spectral response characteristics. As illustrated in Figure 0-4, 





independent of the wavelength of that causal irradiance, whereas the electrical output 
response observed from a quantum detector varies selectively with wavelength.  
When a ‘thermal’ detector material absorbs infrared irradiance, the 
temperature of the detector material changes, and this temperature change causes a 
corresponding change in a physical property of that material. The magnitude of this 
physical property change is used to generate a useful electrical output signal. The 
nature of the signal does not depend upon the photonic nature of the causative 
incident radiation. Thus, thermal effects are generally wavelength independent, and 
the observed electrical output signal depends upon the irradiance (incident Wm-2), or 
rate of change in irradiance, but not upon the spectral content of that incident 
radiation (Figure 0-4). 
 Of all the thermal approaches to infrared detection, bolometers have found 
most widespread utility in TIRI. The key functional attribute of bolometers is their 
temperature-dependent impedance. Bolometers can be divided into several types 
(Figure 0-5), including semiconductor, metal, and superconductor bolometers. The  
 
Figure 0-5. Bolometer types, shown in terms of output response to temperature change, as 





steeper gradients of the more recently developed semiconductor and superconductor 
types talks to advancements in thermal sensitivity that were critical to the recent 
increases in accessibility to TIRI technology. 
In quantum detectors, irradiance is absorbed within the material by interaction 
with electrons. The observed electrical output signal results from the changes in 
electronic energy distribution via optical charge carriers. Quantum detectors exhibit 
wavelength-dependent response to irradiance (Figure 0-4), and when cryogenically 
cooled, can achieve excellent signal-to-noise and response time performance. Cooling 
is necessary to prevent the thermal generation of charge carriers that would compete 
with the functionally critical aforementioned optical charge carriers, and create 
unacceptable levels of noise in the output signal (Rogalski, 2012). The considerable 
cost involved in satisfying these cooling requirements is a major consideration in 
development and use of TIRI systems.  
So in summary, thermal infrared waves (which hold skin temperature 
distribution information) can be converted into digital signals via either quantum or 
thermal phenomena; and the trade-off of quantum’s superior sensitivity but greater 
cost (due to cooling requirements) which has historically been the main consideration, 
has become less important in recent years due to the introduction of high performance 
uncooled bolometers (which are thermal-type detectors). 
1.5 Emissivity and Quantification 
Once infrared emittance has been detected (as above), its quantitative deconvolution 
and interpretation (as required for thermometry) require application of several laws.  
Planck’s Law ( 0.1 ) describes the relationship between the temperature of a 
‘blackbody’, and the wavelengths over which thermal emittance will propagate away 
from that blackbody. A blackbody is a conceptual (as opposed to real physical) body, 
which by definition exhibits the maximum possible thermal emittance for any given 
temperature (Planck, 1901). These blackbody spectral power distributions, or ‘Planck 






Figure 0-6:  ‘Planck Curves’, hemispherical spectral power distributions corresponding to 
thermal emission from a blackbody at various thermodynamic temperatures ranging from 200 - 
4000 K. Red curve indicating clinically-relevant temperatures for human euthermia. 
distributions from real physical bodies can be quantified in context of specified 






 ( 0.1 ) 
   
Where: 
B = spectral emittance [Wm-2m-1] 
T = absolute temperature [K] 
h = Planck’s constant = 6.62 x 10-34 [Js] 
c = the speed of light in vacuum = 3 x 108 [ms-1] 
k = Boltzmann’s constant 1.38 x 10-23 [JK-1] 
 
The Planck function has some useful properties which can be described by ‘Wien’s 
Displacement Law’, ‘The Rayleigh Jean Law’, and ‘Boltzmann’s Law’ (Brooker, 2008). 
Because the radiation process is statistical in nature and a large number of particles 
are involved, a range of wavelengths is radiated as shown in Figure 0-6. By equating 
the first derivative of Planck’s function to zero with respect to wavelength ‘λ’, the 
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( 0.2 ) 
This relation shows that high temperature bodies tend to emit more power at shorter 
wavelengths. In applied TIRI research it is useful to know the wavelength around 






   [𝑊 ∙ 𝑚−2𝜇𝑚−1] 
 
( 0.3 ) 
At longer wavelengths (hc << λkT) the power density per unit wavelength becomes 
proportional to temperature, as represented by the Rayleigh-Jean Law ( 0.3 ). The total 
power density Φ0 within a particular bandwidth (which may be a specific section of a 
full power distribution from a blackbody) is determined by Integration of ‘Bλ‘over that 
bandwidth. This is normally solved numerically ( 0.4 ) or by approximation as there is 








𝛿𝜆       [𝑊 ∙ 𝑚−2] 
 
( 0.4 ) 
If the bandwidth under inspection includes more than 50% of the radiated power then 
the Boltzmann law ( 0.5 ) can be used to approximate the value: 
 
 ∅0 = 𝜎𝑇4      [𝑊 ∙ 𝑚−2] 
 
( 0.5 ) 
Where ‘σ’ is the Stefan-Boltzmann constant (5.67×10-8 Wm-2K-4). 
 
For any given combination of wavelength and temperature, the ratio of thermal 
emittance from a real body (W) to that from a blackbody (B) is referred to as that real 










( 0.6 ) 
Where:  
ε = emissivity [  0 < decimal value < 1 ] 
λ = wavelength under consideration [μm] 
T = absolute temperature under consideration [K] 
B = Blackbody emittance [W m-2 μm-1]   
W = Realbody emittance [W m-2 μm-1]   
 
Figure 0-7 shows emissivity as a function of wavelength. By definition, blackbodies 
always have an omnispectral emissivity of 1.0. Although blackbody emittance is 
isotropic by definition, it should be noted that real-body emissivity is subject to 




Figure 0-7: Spectral relationship between ‘Black’, ‘Grey’, and ‘Real’ emissivities; as correspond to 
a common temperature. Note how the ‘Grey’ characterisation approximates an emissively 





Emissivity. In applied fields such as engineering however, it is customary to work with 
‘hemispheric’ quantities (Figure 0-6), being those averaged over solid angles, i.e. ‘ελT’ 
(Arthur & Khan, 2013).   
In summary, from a technologist’s perspective, medical TIRI entails a sequence 
of physical processes; stemming from thermal physiology, to thermal emission, 
infrared propagation through a clinical atmosphere as an optical medium, to infrared 
detection (quantum or thermal) within a TIRI system, and ultimate deconvolution and 


























THE INFRARED CLINICAL SETTING 
CHAPTER SUMMARY 
This chapter works through a description of the clinical TIRI setting as a system of 
elements that emit, reflect, absorb, or modulate infrared radiation. This infrared 
characterisation of the clinical setting is intended to make subsequent design of clinical 
protocols more manageable and objective (Arthur & Khan, 2011a, 2013).  
The first section of this chapter discusses the IR characteristics of the overall clinical 
setting, with subsequent sections discussing protocol considerations surrounding 
individual components of the clinical setting. 
 
2. The IR Clinical Setting 
 
Figure 2-1. Abstraction of The Infrared Clinical Setting. i) TIRI camera (optoelectronics), ii) 





1.6 The Overall Clinical Setting 
Figure 2-1 is a schematic of the overall clinical setting, showing the main infrared 
elements whose infrared behaviour should be accounted for in a clinical TIRI protocol 
(Arthur & Khan, 2011d). In Figure 2-1, the clinical setting is represented as a thermal 
infrared system comprised of three main subsystems, namely; a TIRI camera, the 
ambient clinical atmosphere, and the physioanatomy under examination. Protocol 
design considerations surrounding each of these three subsystems are discussed 
further in the following sections of this chapter. 
In addition to the three main subsystems, Figure 2-1 also shows the key 
streams of radiation that pass between, and interact with, the subsystems. The 
symbols used in Figure 2-1 to represent these radiation streams and the parameters 
that drive them are explained as follows: 
 Tr =combined effective temperature of ambient sources   [K]  
 Wr = IR emittance from ambient sources  [W] 
 (1-Єs)W = reflected IR emittance from ROI  [W] 
 ЄsWs = IR exitance from tissue volume  [W] 
 Єs = emissivity of tissue volume  [0, 1] 
 Ts = surface temperature of tissue volume  [K] 
 Ta = atmospheric temperature  [K] 
 τ = atmospheric transmittance  [%] 
 τԐsWs = IR emittance from ROI irradiating the lens  [W] 
 τ(1-ԐsWs)Wr = IR emittance from ambient sources irradiating the lens  [W]  
Being aware of all of these streams of radiation and spatially understanding how they 
interact enables more manageable and objective design of protocols to control these 
streams in a manner that best supports the goal of the clinical study. In most cases the 
goal of a clinical TIRI study protocol will be to create conditions that allow acquisition 
of image data containing maximum signal to noise ratio, where the ‘signal’ is ЄsWs 
(thermal infrared exitance from tissue volume [W]), and the ‘noise’ is τ(1-ԐsWs)Wr 





In the field of ergonomics, where products are designed to function in harmony 
with humans, the design process begins with characterisation of human body part with 
which the product will interface, and proceeds by building the product’s necessary 
functionality around that body part characterisation. The same principal applies to 
design of clinical devices and clinical device application protocols, which are both 
driven by the specific with which the device must interact. It follows that development 
of clinical TIRI protocols should begin with detailed thermoradiative characterization 
of the relevant physioanatomy, (item iii, Figure 2-1).  
By the same logic, the subsystem that should be characterized second is the 
ambient clinical atmosphere. After the atmosphere has been characterized, as both an 
effector of physioanatomy and infrared signal propagation, it is possible to identify 
optimal TIRI camera specifications. In the order of phyisoanatomy, atmosphere, 
camera; the following sections walk through an infrared characterisation of the clinical 
setting, as a necessary precursor to objective development of clinical TIRI protocols.  
1.7 Physioanatomy of Interest 
For any given clinical TIRI study, the ‘physioanatomy of interest’ refers to a specific 
body part, in specific physiological circumstances; e.g. the anteromedial aspect of a 
lower leg (anatomy), with a suspected stress fracture in the tibia (physiology). 
Although the physioanatomy of interest will vary from one clinical TIRI case to 
another, the approach required to thermoradiative characterisation of the 
physioanatomy for the purposes of protocol design will be more uniform. As the goal of 
most clinical TIRI studies is to infer internal heat distribution from surface 
temperature distribution (in the form of a TIRI image), characterisation should be in 
terms of both heat transfer within the tissue volume, and external radiative heat 






Figure 1-2-2. 3D Physioanatomy of Interest - highlighted in context of the overall clinical setting 
(left), and in relation to TIRI-obtained surface temperature distribution (right). 
The task of inferring or predicting temperature distributions within unit volumes of 
tissue is typically achieved via computational heat transfer models based upon 
adaptations of Pennes’ seminal ‘Bioheat Equation’ ( 2.1 ) (Pennes, 1948). Pennes’ 
original equation, also known as the ‘continuum model’, has many limitations including 
a basic assumption that all heat transfer between the tissue and the blood occurs in the 






=  𝑘∇2𝑇 +  𝜌𝐶𝑏𝜔𝑏(𝑇𝑎 −  𝑇) +  𝑄 
 
( 2.1 ) 
Where 
 ρ = tissue density [kg·m-3] 
 C = specific heat of tissue [J·kg-1·K-1] 
 T = unknown tissue temperature (as inferred via TIRI) [K] 
 t = time [s] 
 k = thermal conductivity [W·m-1·K-1] 
 Cb = specific heat capacity of blood [J·kg-1·K-1] 





 Ta = arterial blood temperature [K] 
 Q = volumetric metabolic heat generation rate of tissue [W·m-3] 
Although many models based upon Pennes’ equation are cited in the biomedical 
literature, this discussion is limited to those models developed for use in conjunction 
with TIRI, i.e. with ‘TIRI-inferred skin surface temperature’ as the intended input 
parameter. The general form of Pennes’ equation given ( 2.1 ) describes the amount of 
heat transferred from subsurface sources (due to haemodynamics) to the outer surface 
of the tissue, as indirectly perceptible by a TIRI system. Under steady state conditions, 
Pennes’ equation takes the form given in ( 2.2 ) 
 
 0 =  𝑘∇2𝑇 +  𝜌𝐶𝑏𝜔𝑏(𝑇𝑎 −  𝑇) +  𝑄 ( 2.2 ) 
 
The three terms on the right-hand side of ( 2.2 ) represent the rate at which thermal 
energy is considered to enter or leave the unit volume in unit time, by conduction, 
perfusion, and metabolism respectively. This form is applicable where it is valid to 
assume; no large arteries or veins cross the volume of interest, and that the region is 
sufficiently large to make heat transfer to adjacent tissue volumes negligible (Nelson, 
1998). High-fidelity modeling of heat transfer mechanisms in specific physioanatomic 
milieu may conceivably allow extraction of useful physiological parameters from TIRI 
data (Garbey, Merla, & Pavlidis, 2004; Herman & Çetingül, 2011; Pavlidis et al., 2007).  
An example of this is described in (Pavlidis, 2003), where the authors 
developed an augmented version of Pennes’ for use in conjunction with thermometric 
TIRI, for inference of haemodynamic perfusion rate (ωb [kg·m-3·s-1] ). It was argued 
that the heat produced by the body from metabolic processes is transported to the 
cutaneous level (surface of the skin) through conduction and convection, and is lost to 
the environment through radiation, evaporation, and air flow convection (Pavlidis, 
2003). The TIRI-perceptible heat loss ‘qrad’ was modeled as in ( 2.3 ): 
 






 qs = total heat loss from ROI   [W·m2] 
 qrad = radiative heat loss from ROI   [W·m2] 
 qcon = convective heat loss from ROI   [W·m2] 
 qev = evaporative heat loss from ROI   [W·m2] 
Pennes’ ( 2.1 )was then extended to include these three mechanisms of heat 






=  𝑘∇2𝑇 +  𝜌𝐶𝑏𝜔𝑏(𝑇𝑎 −  𝑇) +  𝑄 − 𝑞𝑟𝑎𝑑 − 𝑞𝑐𝑜𝑛 − 𝑞𝑒𝑣 ( 2.4 ) 
 
This model assumes that the blood maintains arterial temperature (Ta) until it reaches 
thermal equilibrium with the skin tissue (Izhar & Petrou, 2012). The unknown tissue 
surface temperature ‘T’ is obtained via quantitative TIRI of the ROI. Using automated 
methods similar to those described in (Pavlidis, 2003) to evaluate physiological 
parameters (ρ, C, k, Cb, Ta) and heat components (Q, qcon, and qev), TIRI-based 
evaluation of ‘qrad’ enables evaluation of blood perfusion rate ωb.  
An identified mathematical problem in TIRI-associated bioheat modeling is the 
retrieval of superficial blood vessel location, and the haemodynamic flow rate within 
those vessels from time-resolved thermometric TIRI data (Izhar & Petrou, 2012). Two 
legacy bioheat transfer models proposed to address the problem associated with the 
vascularity of the underlying tissue were also discussed by (Garbey et al., 2004) and 
(Pavlidis et al., 2007) - the continuum model expressed by ( 2.4 ) and the geometric 
model. 
The continuum model relates haemodynamic perfusion rate to ROI surface 
temperature as a function of the effective conductivity and internal heat sources of the 






Figure 2-3. Geometrical models of anatomic context (xy plane corresponding to TIRI ROI) for 
bioheat transfer models used in conjunction with TIRI studies by (a) (Wilson & Spence, 1988), 
and (b) (Pavlidis, 2003). Figure adapted from (Izhar & Petrou, 2012). 
the geometry of the vascularity.  As one would expect, the major trade-offs include the 
inability of continuum models to represent the heterogeneity of vascular geometry, 
whilst the complexity and variability of superficial vasculature hinders generalization 
of the geometric approach. Hence, a general procedure to solve the problem by 
recovering missing information on vessel morphology and blood flow fluctuations was 
proposed (Garbey et al., 2004; Izhar & Petrou, 2012; Pavlidis et al., 2007). 
With a view to capturing the advantages of both approaches (continuum and 
geometric), a hybrid model was formulated using a partial differential approach with 
specified boundary conditions (Izhar & Petrou, 2012). This directional model describes 
bioheat transfer of large superficial vasculature (in skin), with vessels characterised as 
volumetric heat sources embedded within a thermally passive four-layer tissue 
structure, Figure 2-3. Each tissue layer is assumed to be isotropic in terms of density, 
thermal conductivity, metabolic heat rate, and specific heat.  
The new modelling approach allows scope to include naïve representations of: 
the geometry and the anatomy of tissues surrounding vasculature (with vasculature 
still considered the functional heat source component), the thermal properties of 
surrounding tissues, the general energy balance of vasculature, and vascular geometry 





vascular location and haemodynamic information from TIRI image data corresponding 
to the superficial ROI. 
To capture the advantages of both approaches (continuum and geometric), a hybrid 
model was formulated using a PDE approach with specified boundary conditions 
(Izhar & Petrou, 2012). This directional model describes bioheat transfer of large 
superficial vasculature (in skin), with vessels characterised as volumetric heat sources 
embedded within a thermally passive four-layer tissue structure, Figure 2-3. Each 
tissue layer is assumed to be isotropic in terms of density, thermal conductivity, 
metabolic heat rate, and specific heat.  
The new modelling approach allows scope to include naïve representations of: 
the geometry and the anatomy of tissues surrounding vasculature (with vasculature 
still considered the functional heat source component), the thermal properties of 
surrounding tissues, the general energy balance of vasculature, and vascular geometry 
–enabling bioheat transfer modelling with a fidelity more conducive to retrieval of 
vascular location and haemodynamic information from TIRI image data corresponding 
to the superficial ROI. 
 The PDE describes the unit tissue volume as a Cartesian solid wherein the 
skin’s surface lies in the XY plane, and the perpendicular Z axis extends into the depth 
of the body, Figure 2-3. Assuming universally isotropic thermal conductivity 
throughout the volume, the thermal conductivity ‘k’ term ( 2.4 ), which represents  
 
 
Figure 2-4 (a) An infinitesimal cross section of skin showing entry of heat from the deep muscle 
layer and loss of heat through the superficial epidermis layer. (b) A blood vessel is assumed to be 


















) ( 2.5 ) 
 
Considering a tomographic XZ-plane slice of the unit tissue volume as depicted in 
Figure 2-3b, thermal conductivity will vary with tissue type, which varies as a function 
of depth, i.e. k (z). Further considering an infinitesimal rectangular section of this XZ 
slice, of size ΔX × ΔZ, Figure 2-4, heat entering element ‘ΔX × ΔZ’ is given by ( 2.6 ), and 













 ( 2.6 ) 
   
The difference in ( 2.6 ) represents the heat that remains within element ‘ΔX × ΔZ’, and 
contributes to temperature change over time, i.e. 
𝜕𝑇
𝜕𝑡
. Normalising this difference by 
division over the length of ΔZ gives time-resolved temperature variation per unit 























( 2.7 ) 
 
Similarly, the time-resolved temperature variation within element ‘ΔX × ΔZ’ per unit 






).  Thus, the 𝑘∇2𝑇 (thermal 
conductivity) term in the higher fidelity ( 2.5 ) representation of Figure 2-3b becomes 


















Assuming that the (𝜌𝐶𝑏𝜔𝑏(𝑇𝑎 −  𝑇)) term in ( 2.1 ) represents the heat transported by 
a blood vessel running along the x-axis at a constant depth below the epidermis-
atmosphere interface, and denoting that heat flow by qb (x, t), then the bioheat transfer 


















) = 𝑞𝑏(𝑥, 𝑡) + 𝑄(𝑥, 𝑧) ( 2.9 ) 
 
The right-hand side of this equation represents conduction of the heat produced 
through the control volume tissue and fluctuates over time as expressed by the spatial 
and time derivatives of the left-hand side of the equation (Pavlidis et al., 2007). In this 
model, the vessel acting as the heat source is assumed to be a cylinder centred on line Z 
= s (at constant depth z, Figure 2-4b), transferring heat as qb = ub(t)r(x, z), where ub(t) 
denotes haemodynamic flow rate, and r(x, z) is a function ( 2.10 ) modelling heat 
transfer away from the vessel: 
 
 
𝑟(𝑥, 𝑧) ≡ 𝜇 exp (−
(𝑧 − 𝑠(𝑥))2
𝜋𝑣𝑎𝑝𝑝2
) ( 2.10 ) 
 






(𝑇𝑎(𝑥, 𝑧, 𝑡) − 𝑇(𝑥, 𝑧, 𝑡)) ( 2.11 ) 
 
Where A represents the cross sectional area of the blood vessel, and V is a normalising 
volume of tissue. For testing, the PDE model ( 2.9 ) was used in conjunction with a TIRI 
system to predict the time-varying haemodynamic flow rate in a major superficial 
blood vessel (Pavlidis et al., 2007), as useful in monitoring for heartbeat irregularities. 
The input to the model was the TIRI-inferred temperature ‘T’ of the skin overlying the 





All other parameters required for inverse solution of ( 2.9 ) were either measured or 
assumed, and validation data Figure 2-5a) was obtained via contact blood flow meter. 
The biometric utility of TIRI illustrated in Figure 2-5 has been investigated for 
diagnosis of several medical conditions and affective states (M. Khan et al., 2006; M. 
Khan et al., 2009). Ways in which this directional PDA model augments Pennes’ 
original include: 
 Use of a Gaussian ( 2.10 ) to model the heat transferred by the vessel, allowing 
adaptation to arbitrarily complex vascular geometries, 
 Multilayer representation of the surrounding tissue, 
 Assumed modulation of vessel heat power via control of haemodynamic flow 
rate,  
 And fundamental representation of vessels as a heat sources. 
In terms of radiative heat transfer from the outer surface of the skin (the ROI) to the 
TIRI system, there have been two modelling paradigms to date: the first representing 
superficial skin tissue on all parts of the body as a greybody emitter with emissivity ≈ 
0.98 Figure 2-6a, and the second representing superficial tissue as having significant 
transmissivity 0.98 Figure 2-6b. The greybody (b) has conventionally been employed 
in applied human TIRI, such as the during the SARS and avian flu pandemics of 2003 
and 2008, when several governments deployed 
 
 
Figure 2-5 (a) time-resolved haemodynamic flow rate in the carotid artery according to contact 
blood flow meter (Vasimedics®), (b) Time-resolved temperature of skin surface directly 
overlying the carotid artery monitored in (b), according to a thermometric TIRI system. 





quantitative thermometric TIRI systems to mass screen for febrile TIR emittance 
profiles in hospitals and at border control points (Çetingül & Herman, 2010c; Ng & 
Acharya, 2009; Ring & Ammer, 2012).  
This model has been found sufficient in other such applications where tolerance 
of variable ambient conditions over large lens-object distances is required, efforts 
toward quantitative deconvolution of imaged human emittance are redundant. In 
controlled clinical or laboratory environments, however, one may consider more 
sophisticated modes of application that exploit TIRI’s noncontact, noninvasive, and 
nonionizing features (Arthur & Khan, 2011d; Çetingül & Herman, 2010c; de Weerd, 
2010b).  
First, TIRI hardware may be readily configured to afford sufficiently stable 
spatial resolution at the region of interest (ROI) for meaningful pixel-based analyses 
(Arthur et al., 2011a; M. Khan et al., 2009) and second, controlled ambient conditions 
give scope for quantitative deconvolution of measured emittance via online inference 
and mapping of spatiotemporal variations in emissivity (Arthur & Khan, 2013). 
Departure from the greybody convention followed reports of greater emittance from a 
305 K human face (a large inhomogeneous ROI) than from a 305 K radiometrically 
calibrated Ԑ > 0.99 
 
 
Figure 2-6. Schematic of the two prevalent TIRI-compatible bioheat transfer models, (a) The 
Greybody Model, featuring global omnispectral emissivity of 0.98 at (L, 0) with subsurface heat 
transfer entirely conductive and convective, as in (Çetingül & Herman, 2010b). (b) The 
Transmissive Model, with selective emissivity at the outer surface, a low index of refraction ‘n’ at 
the skin-air interface, significant TIR transmissivity in superficial tissue layers, significantly 
greater absorptivity (α) within the deepest tissue layer, and common skin temperature Tsk and 





blackbody source during the DARPA HID program. By definition, a blackbody source 
exhibits greater emissive power at a given surface temperature than a real physical 
body at that same temperature, so the discrepancy was attributed to significant 
transmissivity of the superficial tissue layers to emittance from deeper sources.  
These findings led to development of the model shown in Figure 2-6b, 
characterised by selective emissivity at the outer surface, a low index of refraction ‘n’ 
at the skin-air interface, significant TIR transmissivity in superficial tissue layers, 
significantly greater absorptivity ‘α’ within the deepest tissue layer, and common skin 
temperature Tsk and core temperature Tcore boundary conditions at (L, 0) and (L, n).  
It should be noted that as Kirchhoff’s law stipulates that ‘the emissivity of a 
body in thermal equilibrium will be equal to its absorptivity’, such that a body with an 
emissivity ≈ 0.98 should also have an absorptivity ≈ 0.98, and given that reflection, 
absorption, and transmission of incident radiation are related as: 𝜌𝜆𝑇𝜑 + 𝛼𝜆𝑇𝜑 +
 𝜏𝜆𝑇𝜑 = 1.0,  (Figure 2-7) - that transmissivity tends to 0.0 as emissivity tends to 1.0. 
Even when the thermal equilibrium requirement is realistically relaxed, the fact that 
transmissivity tends to 0.0 as emissivity tends to 
 
 
Figure 2-7. Relation of reflection (ρ), absorption (α), and transmission (τ) of a physical body to 
irradiance (Φ), illustrating the inverse proportionality of absorptivity and transmissivity, in 
context of the direct proportionality of absorptivity and emissivity (Ԑ), as applicable to the 





1.0 calls the validity of both radiative bioheat modelling assumptions (Figure 2-6) into 
question. It should also be noted that accurate characterisation of these 
thermophysical properties of superficial tissue is both critical to solution of the 
forward problem in clinical TIRI, and directly bounds the resolution of solutions to the 
inverse problem – thus, rigorous evaluation of the thermophysical characteristics of 
superficial human tissues is critical to the development of TIRI for clinical applications 
(Arthur & Khan, 2013).  
1.8 Ambient Clinical Atmosphere 
Characterisation of the ambient clinical image-acquisition atmosphere is a necessary 
precursor to protocol design, as the atmosphere constitutes; an optical medium for IR 
radiation streams, a stimulus to the physioanatomy of interest, and a source of TIR 
noise, as shown in Figure 2-8, where: 
 Ta = atmospheric temperature  [K] 
 τ = atmospheric transmittance   [%] 
 τԐsWs = TIR emittance from ROI irradiating the lens  [W] 
 τ(1-ԐsWs)Wr = TIR emittance from ambient sources irradiating the lens  [W]  
 
  
Figure 2-8. Ambient Clinical Atmosphere, in context of clinical setting (left), as an optical medium 





Figure 2-9 characterises the ambient atmosphere as an optical medium to for human 
thermal infrared emittance (represented by the red curve). Due to the molecular 
composition of the atmosphere, the certain parts of the infrared spectrum allow 
passage of infrared emittance, whereas others are completely opaque; e.g. atmospheric 
H20 molecules absorb 100% of emittance within the 5.4-7.6μm band, leading to 0% 
transmittance. Conversely, the 3-5µm MWIR (midwave infrared) and 8-14µm LWIR 
(longwave infrared) band exhibit both significant human emittance and transmittance, 
making these the most popular bands for effective clinical TIRI image acquisition.  
Although there are regions beyond 14µm in which significant human emittance 
and atmospheric transmittance coexist, current availability of sensitive IR detector 
technology precludes them from consideration for clinical research applications 
(Arthur & Khan, 2011d; Rogalski, 2011). When characterising the ambient atmosphere 
as a source of IR noise, it should be noted that illumination invariance in the LWIR is 
not completely ideal, and identification of optimal illumination parameters requires 
further investigation (L. Wolff, Socolinsky, & Eveland, 2001). Characterisation of the 
atmosphere as a physiological stimulus to determine optimal ambient conditions for 
image acquisition is a critical aspect of  
 
 
Figure 2-9. Spectral variations in atmospheric transmittance (black) to human thermal infrared 





clinical TIRI research that has received little attention in the literature (Borten, Ransil, 
Di Leo, & Friedman, 1984; Roy, Boucher, & Comtois, 2006; Zaproudina, Varmavuo, 
Airaksinen, & Närhi, 2008). In the majority of cases it will be desirable to foster 
thermoneutral conditions within which thermoregulation is actuated almost solely by 
peripheral vasomotion, with extremely limited perspiration, no shivering, and minimal 
catabolic thermogenesis (Arthur et al., 2011b). Recent approaches employ multi-node 
models of human thermoregulation to predict human thermophysiological and 
thermal sensation responses to wide ranging steady and transient boundary 
conditions, as illustrated in Figure 2-10  (Fiala et al., 2010).  
Recent efforts to establish these conditions have coupled CFD indoor-
environment models, with biocybernetic finite-element human thermoregulation 
models to simulate the overall thermal interaction between a human body and it’s 
climate controlled host indoor environment (Fiala et al., 2010). Successive iterations of 
the IESD-Fiala model (Figure 2-10a) predict the thermal response of the body to the 
current ambient conditions provided by ANSYS CFX (Figure 2-10b). The resultant new 
skin surface properties are then fed back to CFX as inputs, with continued bidirectional 




Figure 2-10 Temperature and (a) air velocity (b) distribution around a temperature-regulated 





1.9 Thermal Infrared Cameras 
Having accurately characterised both the physioanatomic context and the ambient 
clinical atmosphere, it is possible to characterise a compatible TIRI camera system 
performance and associated optical configuration. Holistic characterisation of TIRI 
system performance with a view to use in research toward advancement of TIRI for 
clinical applications is most meaningfully done in terms of a figure of merit known as 
the ‘noise equivalent temperature difference (Arthur & Khan, 2011d).  
Noise equivalent temperature difference (NETD) is defined as the difference in 
temperature between two adjacent blackbody sources of significant lateral extent 
which, when viewed by the TIRI system, gives rise to a difference in signal-to-noise 
ratio of 1.0 in the electrical outputs of the two halves of the array (Niklaus, Vieider, & 
Jakobsen, 2008). 
  Infrared imaging systems based on uncooled bolometer arrays can reach 
NETD’s below 25 mK with an F number (ratio, focal length : entrance pupil diameter) 
of 1.0 (Niklaus et al., 2008). For the aforementioned uncooled TIRI systems based on 
bolometer FPA’s with column based ROIC designs, and assuming bolometer 
temperature is equal to ambient atmospheric temperature (Ta, Figure 2-1ii) the 
overall NETD can be expressed in terms of its constituent noise components (1/f, 
Johnson, thermal, and ROIC noise), as in ( 2.12 ): 
 
 
Figure 2-11. The TIRI camera system, in context of overall clinical setting (left) and as a focal 










2  ( 2.12 ) 
Where: 
NETD1/f  =  
1
𝑓



























 ( 2.13 ) 
 


















∙ 𝑇𝐶𝑅 ∙ 𝑈𝑏𝑖𝑎𝑠
   ( 2.14 ) 
 
NETDthermal = thermal fluctuation noise from the bolometers and heat exchange, given 
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𝑇𝐶𝑅 ∙ 𝑅𝑅𝑂𝐼𝐶 ∙ 𝑽𝑹𝑶𝑰𝑪
−1  
 
( 2.16 ) 
where; 


















 F = ‘F number’, = ‘focal length : aperture diameter’ ratio 
 Φλ1-λ2 = transmittance of optics in bandwidth λ1-λ2 
 G = thermal conduction between each bolometer and surroundings 
 C = heat capacity of bolometer pixel 
 TCR = temperature coefficient of resistance of bolometer material 
 K = 
1
𝑓
 noise constant of bolometer material 
 v = volume of resistive bolometer material  
 T1 = bolometer membrane temperature 
 Rbol = bolometer resistance at temperature T1 
 Β = bolometer pixel fill factor 
 A = bolometer pixel pitch (effective area) 
 Ԑλ1-λ2 = infrared absorbtion rate of bolometer membrane in waveband λ1-λ2 
 xi = number of bolometer pixels per column 
 fi = frame rate (readout frequency) 
 fs = array shutter correction frequency 
 Ubias = bolometer bias frequency 
 RROIC = ROIC input impedance 
 VROIC = total noise voltage of ROIC 
 Vamp = input reference noise voltage 
 VQ = input reference quantisation interval 






 = temperature contrast in waveband λ1-λ2 
  ω = modultation frequency of the IR biosignal from the tissue ROI 
 k = Boltzmann constant = 1.381 × 10-23 m2 kg s-2 K-1 
In addition to physics-based thermometric performance criteria, design of clinically-
directed TIRI research also requires characterisation of TIRI cameras in terms of 
optical configuration requirements such that the instantaneous fieold of view yileds 






Figure 2-12. Schematic illustration of optical configuration design for IFOV (instantaneous field 
of view) in context of: clinical image acquisition setup, critical ROI anthropometry, FPA 
dimensions, and resulting spatial resolution on the surface of the tissue ROI (Arthur & Khan, 
2011d; Arthur et al., 2011b). 
In summary, the clinical TIRI setting can be characterised as a system of elements that 
emit, reflect, absorb, or modulate infrared radiation. Having a detailed understanding 
of heat transfer within the physioanatomy, and the clinical atmosphere as both  an 
optical medium and physiological stimulus, allows selection and calibration of 
appropriate TIRI camera technology. This infrared characterisation of the clinical 
setting enables manageable design of objective clinical protocols, which can lead to 
acquisition of superior clinical data and ultimately to improved patient outcomes 
















DEVELOPMENT OF CLINICAL TIRI PROTOCOLS 
CHAPTER SUMMARY 
This chapter builds on the generalisable infrared characterisation of the clinical setting 
provided in chapter 3, to develop specific clinical protocols for a TIRI study into 
osseous stress pathology (OSP) in the tibia. Developing a protocol for a specific 
pathoanatomic context is valuable as an opportunity for learning general lessons about 
clinical TIRI protocol development, and delivers a protocol that can be implemented in 
clinic to give empirical insight to TIRI’s utility in a promising application. Tibial OSP 
was chosen for its strong thermal component, superficial homogenous anatomy, high 
prevalence in an available test population, and a high-consequence differential 
diagnosis that could benefit from additional decision support. This chapter walks 
through the building of necessary understanding, and rationale for key design 
decisions made in development of a protocol for clinical study of TIRI’s utility in 
management of tibial OSP in an Australian military basic trainee population. 
 
3. Image Acquisition Protocols 
The improved reproducibility of body positions and ROI locations has been shown to 
have a marked influence on both the accuracy and precision of temperature 
measurements obtained from clinical thermal infrared images (Ring & Ammer, 2012). 
Moreover, the historical lack of objective protocols for coherent clinical and 
laboratory-based data acquisition and processing has precluded clinical TIRI from 
establishing critical mass in epidemiological consistency, specificity, temporality, and 
reversibility (Ammer, 2008; Clark & Calcina-Goff, 1996; Plassmann, Ring, & Jones, 
2006; Simpson, 2008). 
Previous human TIRI systems can be functionally characterised as ‘two-





applications for which these expert systems are designed require robust operation 
under variable conditions, their underlying classifiers are trained with appropriately 
noisy human TIRI data, acquired under accordingly lenient image acquisition protocols 
such as those pertaining to febrile screening (IEC/DIS, 2008; ISO, 2009). 
The envisaged advanced mode of clinical TIRI may be characterised as 
‘quantitative three-dimensional radiometry’. This quantitative physics-critical mode of 
application is tasked to achieve greater specificity than previous systems; despite 
being without the spatial and convolutional abstraction layers and more forgiving core 
task that gave previous systems their operational robustness. As advanced clinical TIRI 
will not be able to achieve this ambitious brief under the variable image acquisition 
conditions tolerated by legacy systems, development of objective image acquisition 
protocols is critical for advancement of clinical TIRI for clinical applications. 
1.10 Approach to Protocol Development 
The purpose of medical image acquisition protocols is to guide implementation of 
controlled conditions and practices that are most conducive to acquisition of high 
fidelity image data that contain as much clinically-relevant information as possible 
(Hawkes et al., 2010). The maturely developed protocols for image acquisition with 
established medical imaging modalities are multifaceted, with certain elements of 
these protocols being applicable every time a certain modality is used, and others only 
applicable when certain pathology or anatomy are involved in the imaging 
investigation (Abbey & Eckstein, 2012; Carver & Carver, 2010).  
The more generally applicable aspects of medical image acquisition protocols 
often stem from the fundamental physics of the modality, in the form of measures 
taken to mitigate potential sources of spectral noise within the clinical image 
acquisition setting, and accentuate the signal of interest. Prior selection of a particular 
pathoanatomic context provides a helpful framework for subsequent protocol 
development, with the vast majority of protocols developed around a particular 
pathoanatomic context being applicable to all clinical investigations with the subjective 





experimental design and execution of real clinical studies, allowing discovery of 
practical image acquisition issues that might remain unconsidered in solely 
laboratory-based development, resulting in richer protocols with greater pragmatic 
utility, whilst generating valuable clinical data.  
Accordingly, it was decided to approach the development of image acquisition 
protocols for clinical TIRI by first identifying a suitable pathoanatomic context, where 
suitability is primarily characterised by: a significantly thermoactive 
pathophysiological mechanism that is prevalent in a readily accessible population; and 
an anatomic setting that is both superficial and unoccluded by thermogenic anatomy 
(Arthur & Khan, 2011d; Arthur et al., 2011b; Pascoe, Mercer, & de Weerd, 2008). 
Preference was also given to host tissues (anatomic context) exhibiting static rigidity 
and low lipid concentration, as conducive to thermometric validation of clinical TIRI 
data via PRF (proton resonance frequency)-based MRI sequences (Arthur & Khan, 
2013; Kagayaki, 2005; Rieke & Pauly, 2008; Taylor et al., 2011). P Pathologies 
with serious differential diagnoses that stood to gain from an additional diagnostic 
decision support tool were also prioritised. As detailed in (Arthur et al., 2011b), clinical 
TIRI image acquisition protocols were developed in pathoanatomic context of ‘osseous 
stress pathology in the anteromedial aspect of the tibia’ (described in detail below). To 
bring similar benefits of a focusing pathoanatomic context, the demographic context of 
the Australian Army Military Basic Trainee population was also specified prior to 
protocol development (Arthur & Khan, 2011b).  
Following characterization of the implications of these contextual tissue ROI 
constraints (Figure 3-1iii) upon protocol development, and in alignment with the 
broader systems architecture (Figure 3-1), clinical TIRI image acquisition protocols 
were developed to technically address ‘optical configuration’ (Figure 3-1i) and 







Figure 3-1. The infrared clinical setting (Arthur & Khan, 2011d). 
1.11 Pathoanatomic Context  
This section provides: rationale for the decision to develop clinical TIRI image 
acquisition protocols in pathoanatomic context of ‘anteromedial tibial stress 
pathology’ (Figure 3-1 iii), and, a characterisation of the aspects of tibial stress 
pathology relevant to TIRI image acquisition protocols. Osseous stress 
pathophysiology features focal thermodynamic mechanisms including hyperemia, and 
both osteocytic and hyperalgesic nitric oxide production (Saini, Yadav, & McCormick, 
2011).  
In anatomic context of the anteromedial aspect of the tibia (Figure 3-2 and 
Figure 3-3) where OSP is most prevalent (Itskoviz, Marom, & Ostfeld, 2011), these 
mechanisms occur within a thin superficial volume of thermodynamically determinate 
tissues (Arthur et al., 2011b), unoccluded by thermogenic anatomy or dissipative heat-
sinking vasculature  (de Weerd, 2010b; Pascoe et al., 2008).This contrasts with the 
complex network of tissues interstitial to the metatarsals (the second most prevalent 
OSI site) and the dorsal aspect of the foot, as shown Figure 3-3 (Itskoviz et al., 2011; 
Phillipson & Parker, 2009). Moreover, the pretibial tissue volume exhibits the static 






Figure 3-2. Anteromedial pretibial tissue volumes excised from a cadaver at Curtin University 
School of Biomedical Sciences spanning mediolaterally from the thermophysical boundaries of 
the superficial posterior to the anterior compartments. Enlarged excision views (inset above) 
showing the thin homogeneous nature of tissue interstitial to the exposed periosteum. 
thermometric validation of clinical TIRI data via PRF (proton resonance frequency)-
based MRI sequences (Arthur & Khan, 2013; Kagayaki, 2005; Rieke & Pauly, 2008; 
Taylor et al., 2011).Osseous stress injury (OSI) is a significant cause of inactive 
downtime in athletic and military populations, constituting 10% of all athletic injuries 
(Goodman, Heaslet, Pagliano, & Rubin, 1985; Phillipson & Parker, 2009). The 
differential diagnosis of OSI includes extremely serious conditions that require 
significantly different treatment and management to OSI, such as osteoid osteoma and 






Figure 3-3. Exploratory dissection of pre-metatarsal tissues from a cadaveric specimen at Curtin 
University School of Biomedical Sciences, showing complex network of tissues interstitial to the 
metatarsals (a site of high OSI prevalence) and the dorsal aspect of the foot that would constitute 
the ROI in a clinical TIRI study. The relative vascularity and complexity of these tissues to those 
in Figure 3-2 illustrates the rationale for selection of the pretibial tissues as pathoanatomic 
context for protocol development and clinical study. 
-(Daffner et al., 2008; Dugert et al., 2010; E. Dugert, 2010; Heun & Jatoi, 2009; A. Khan, 
Chandramohan, Turnbull, & MacDonald, 2009; Lew & Waldvogel, 2004; Mader & 
Calhoun, 2000; Nagashima, Nishi, Yamane, & Tanida, 2010). The possibility of 
discovering TIRI’s ability to improve the rate of correct OSI diagnoses (as suggested by 
(Goodman et al., 1985)) makes OSI an even more attractive pathophysiological context 
within which to develop clinical TIRI protocols. 
The term ‘osseous stress injury’ describes the pathophysiological continuum of 
progressive rarefaction of bone by a physiological mechanism known as both ‘active 
remodelling’ and ‘secondary bone formation’ in accordance with ‘Wolff’s Law’ Figure 
3-4 (Schindeler et al., 2008; J. Wolff, 1986). Clinically significant points along this 
continuum include those of; ‘stress reaction’, when the volume of interest initially 
becomes hyperalgaesic following periods of  load-bearing; ‘stress change’, when the 
sub-threshold physiological correlates of hyperactive remodelling first become 





correlates of rarefaction evident on imaging are sufficiently significant to warrant a 
prescribed period of convalescent rest (Barclay, 2010; Daffner et al., 2008; Rae, 2010).  
When a long bone is subject to mechanical stress, the ensuing deformation 
induces a flow in the interstitial fluid of the lacunar-canalicular system of the cortex, 
shown as ‘q’ in Figure 3-4 (Danova, Colopy, & Radtke, 2003; Knothe tate, Steck, 
Forwood, & Niederer, 2000; Mak, Qin, Hung, Cheng, & Tin, 2000; Piekarski & Munro, 
1977; Tami, Schaffler, & Knothe tate, 2003; Wang, Ciani, Doty, & Fritton, 2004; Wang et 
al., 2005). Deformation is also thought to induce a piezoelectric charge gradient from 
the electronegative compression side ‘x’ to the electropositive tension side ‘-’of the 
cortex, Figure 3-4 (Baxter, Bowen, Turner, & Dent, 2010; Breithaupt, 1855; Fu, 2010; 
Fukada & Yasuda, 1957; Lakes, 2008; Webb & Tricker, 2000).  
 
 
Figure 3-4. The mechanism of osseous stress pathology. Both pathogenetic and perpetuating 
through pathology – with stressing forces shown as red arrows; cortical bone shown in grey; 
endosteal and periosteal connective tissues shown as layers of red either side of the cortex; 
omnidirectional interstitial fluid flow ‘q’ shown in blue; piezoelectric charge gradient (X - -), also 





The osteocyte cells of the cortex have been implicated as the osseous 
‘mechanotransducers’, detecting these stress-induced changes, releasing RANKL and 
nitric oxide molecules, and activating local osteoclasts (Bacabac et al., 2008; Chen, Liu, 
You, & Simmons, 2010; Jacobs, Temiyasathit, & Castillo, 2010; Philips et al., 2008; Tan 
et al., 2007; Tatsumi et al., 2007). These conic osteoclasts (green ‘O’, Figure 3-4) then 
secrete proteolytic enzymes, drilling 3-10mm tunnels through the cortex normal to the 
axes of the inducing stress forces (Breithaupt, 1855; Engh, Robinson, & Milgram, 1970; 
Lech & Iwaniec, 2010).  
Osteoblastic cells then fill these ‘Haversian canals’ with a mineral matrix, 
requiring approximately one week to structurally mature into new bone fibres, during 
which the periosteum becomes markedly inflamed (Albright & Brand, 1987; Li, Zhang, 
Chen, & Chen, 1985; Romani, Gieck, Perrin, Saliba, & Kahler, 2002). Continued stressful 
activity during this weakened period can exacerbate theperiosteal inflammation, 
induce oedema in the proximal marrow, and propagate cortical micro-cracks with 
potential for coalescence into clinical ‘stress fracture’ and marked local production of 
nitric oxide (Kidd et al., 2010; Phillipson & Parker, 2009; Sommer & Kress, 2004).  
Although cortical bone itself does not contain any nociceptors, local 
hyperalgesia ensues via penetration of cortical fragments into the highly innervated 
proximal periosteum and endosteum (Figure 3-4), and pressure from resultant 
haemorrhage oedema (Athanasou, 2009; Wedro, 2009). The multiple routes to NO 
production, combined with the certainty of periosteal inflammation and potential for 
haemorrhage oedema, easily satisfy the criteria for TIRI applicability in the 
pathogenetic and initial clinical stages (Pascoe et al., 2008; Phillipson & Parker, 2009).  
Despite the abundance of available epidemiological information pertinent to 
trauma-induced fracture in structurally sound bone, there is none objectively 
pertaining to the physiological mechanisms of repair specific to stress fractures, as any 
biopsy material obtained in differential diagnosis is typically discarded following tests 
for metastasis and osteomyelitis (Kidd et al., 2010; Mori, 2000). However, as stress 
fractures are non-displaced and feature near-perfect apposition with minimal necrosis, 





compression osteosynthesis as the dominant mechanisms of repair (Athanasou, 2009; 
Einhorn, 1998; McKibbin, 1978; Mori, 2000).  
Nonetheless, continued stressing of the symptomatic bone may compromise the 
stability condition, inducing some degree of the well documented, more inflammatory, 
and more hypercatabolic secondary mechanism of fracture healing (Athanasou, 2009; 
Einhorn, 1998; McKibbin, 1978; Mori, 2000; Schindeler et al., 2008). The lack of 
pertinent prior data preclude objective prediction of the potential benefit of TIRI in 
monitoring and staging of the healing process, yet it should be noted that (Goodman et 
al., 1985) reported a temporal correlation between the appearance of ‘cold spots’ and 
the point of safe return to activity, with the caveat that this occurred in a single subject 
on a single occasion. 
1.12 Demographic Context 
This section provides: rationale for the decision to develop clinical TIRI image 
acquisition protocols in demographic context of the ‘Australian Defence Force Basic 
Trainee Population’, and, a characterisation of the aspects of this population relevant 
to TIRI image acquisition protocols, in context of osseous stress pathology. As with 
pathoanatomy, selection of a specific population to whom protocols may be targeted 
facilitates protocol development, with the vast majority of protocols developed for a 
particular demographic applicable to clinical investigations of all populations with the 
subjective imaging modality.  
Given pathoanatomic context, it should be noted that the debilitating pathology 
of OSI accounts for 10% of all athletic injuries (Phillipson & Parker, 2009), with 
prevalence as high as 20% in modern military basic training cohorts (Itskoviz et al., 
2011). Moreover, increasing concerns surrounding adverse effects of radiology 
(Schenkman, 2011), combined with the 12.5% contribution of diagnostic imaging to 
Australian Medicare benefits paid in 2009-10 have prompted several programs 
directed toward alternative/adjunct electronic decision support systems (Hricak et al., 






Figure 3-5. Nurse unit manager and author (left) addressing a platoon of recruits (right) at the  
Australian Defence Force Health Centre, Kapooka Basic Training Facility, Blamey Barracks, NSW. 
Optical image acquisition configuration shown in the central background. Defence participants 
shown right. 
The work described in this thesis coincided with two such initiatives, namely the third 
and ongoing phase of the Australian DMO (Defence Materiel Organisation) Joint Project 
2060, and the current CMVH (Centre for Military & Veteran’s health) research initiative 
addressing the acquisition and introduction of new health technologies that enhance 
deployable health capability (Arthur & Khan, 2011e; DMO, 2010). Diagnostic imaging 
is a DMO focus area, with Phase 2A and Block 1 seeing the introduction of portable 
ultrasound and digital X-ray systems, and Defence have demonstrated air-worthiness 
and TGA certification of TIRI systems as Medical Devices (GMDN 17888) (Arthur & 
Khan, 2011e; DMO, 2010).  
Accordingly, the ADHREC (Australian Defence Human Research Ethics 
Committee) granted access to Defence medical facilities and cooperation of personnel 
for the development and testing of clinical TIRI image acquisition protocols, for 
interrogation of tibial osseous stress pathology in basic trainees (Arthur & Khan, 





led to Curtin University HREC Protocol #62/2010, AHDREC Protocol #592-10, and 
Australian New Zealand Registered Clinical Trial #12611000623998 (M. Khan, 2011). 
It should be noted that the Australian Institute of Sport was also investigated as a 
potential testing population, but were found to have far lower incidence and 
prevalence of OSI than the ARTC (Australian Recruit Training Centre), and also lacked 
the experimental controls afforded by a military training environment. In order for a 
protocol #592-10 to be endorsed by the ADHREC, it was subject to methodological and 
scientific internal review within the DSTO (Defence Science & Technology 
Organisation).  
These internal reviews are initially screened by DSTO Research Leaders with 
both higher authority on the science involved (medical imaging, experimental 
radiometry, pathophysiology), and independence from the subjective research project. 
In cases such as this where the protocol under review (592-10) is considered in 
context of an existing research initiative (DMO Project 2060), the protocol is reviewed 
by the existing SAC (Scientific Advisory Committee) assigned to that larger initiative. 
Iterations of the protocol were prepared in consultation with a diverse team of senior 
military and medical staff at Kapooka Health Centre and RAP (recruit aid post), 
including radiologists, nurse unit managers, physiotherapists, and relevant 
commanding officers.  
The protocol was accepted as a pilot study into the utility potential of TIRI in 
detection and monitoring of stress-related bone pathology. The ADHREC were 
particularly interested in the utility potential of TIRI in guiding diagnosis and 
treatment of stress reactions / changes /fractures, and monitoring their healing to the 
point when it is safe for ADF basic trainees to resume activity. Stress fractures 
currently result in costly/disruptive downtime for military recruits and civilian 
athletes, so acceleration of identification / diagnosis, safe return to activity is 
invaluable. 
 In the case of ARTC, those recruits showing symptoms of stress injury are 
conservatively sent for MR and/or Bone Scan imaging at the cost of defence during 
scheduled training time. If imaging returns positive for stress “fracture” recruits are 





repairable within 4 months’, they are discharged (Barclay, 2010; Rae, 2010). If imaging 
returns negative for stress “fracture” but shows stress reaction/changes (periostitis, 
hyperalgesia, marrow oedema, and osteoporosis) the recruit is withdrawn from training 
and sent to the rehabilitation platoon.  
Whilst on convalescence leave recruits heal at various points up to the 6 week 
mark but the cost, inconvenience, and ionising dose associated with repeated imaging 
make it more sensible for all convalescents to rest for the full 6 weeks. Those sent to 
the rehabilitation platoon are constantly monitored for improvements in symptoms 
and functionality, with repeated MRI or bone scan (nuclear scintigram) as deemed 
necessary, and at the cost of defence. Bone scans involve injections & high doses of 
ionising radiation, and both MRI and bone scanning are expensive, time-consuming, 
and require skilled operators and purpose-built immobile facilities. Thermal imaging 
has none of these disadvantages, and was deemed to have reasonable potential to 
provide sufficient information to guide treatment in a large proportion of cases. 
Understanding the utility of TIRI in this context requires longitudinal TIRI on recruits 
at the various stages through stress pathology, and comparison with clinical 
presentation, nuclear scintigraphy, and MRI (M. Khan, 2011). 
Given the hierarchical nature of the ADF, ADHREC approval required 
justification for this research being conducted within Defence as opposed to the wider 
community. This justification stemmed from Kapooka Health Centre having the largest 
regular concentration of fatigue-type stress fractures in Australia, making it the ideal 
venue for this research. Moreover, in a civilian health centre there is no guarantee that 
any number of stress fractures will arise within a given period. Furthermore, as the 
health professionals at Kapooka are exposed to the greatest number of stress fractures 
it follows that they should be among the best at identifying and managing them, 
making their insights into our clinical practices and TIRI image acquisition protocols 
invaluable.  
The highly organised nature of the ARTC physical training and rehabilitation 
schedules also allows researchers to cross-reference any physiological changes 
revealed in the thermal scan to the physical activities of the participants. The impact of 





populations) requires protocols to pay particular attention to clear explanation of 
management options should an abnormality or unexpected result arise. Of particular 
concern to were avenues for functional trade tests and reallocation, as addressed in 
part 4e of protocol #592-10. 
1.13 Optical Configuration 
Given anatomic context of the anteromedial aspect of the tibia, and demographic 
context of the ADF basic trainee population, it is possible to design the optical 
configuration for clinical TIRI acquisition, Figure 3-6 (Arthur et al., 2011b). An ad-hoc 
camera mounting system was constructed to steadily maintain the lens to skin-surface 
distance (‘D’ Figure 3-6), with the optical axis normal to the patient bed.  A FLIR 
ThermoVisionTM A40V thermal infrared camera featuring a 7.5 to 13.0 μm uncooled 
bolometric FPA and thermal sensitivity of 0.08° C was used in the  
 
 
Figure 3-6. Schematic relationship between (Left) optical configuration for clinical image 
acquisition, and (right) exploded view of optical design parameters impacting spatial resolution 
achieved at the surface of the tissue ROI. Where: ‘Lroi ‘ = ROI length (popliteal height), ‘D’ = Lens to 
ROI surface distance, ‘i’ = FPA, ‘ii’ = individual FPA element, ‘ƟIFOV’ = instantaneous angular field 
of view of ‘ii’ element, ‘iii’ = lens, ‘Dmax’ = maximum lens-ROI distance permissible for a given IFOV 
at ROI surface, ‘L1’ = IFOV diameter at ROI surface, ‘iv’ = ROI surface. Enlarged view of optical 
configuration for clinical image acquisition (above Left) shown Figure 3-6. Enlarged view of 
optical design parameters impacting spatial resolution achieved at the surface of the tissue ROI 





configuration shown in Figure 3-6 (FLIR, 2004, 2011).  The optical configuration was 
optimised for a longest dimension of the region of interest (Lroi) ≤ 515mm in 
accordance with 95th percentile ‘popliteal height’ as defined in ISO/TR 7250-2:2010 
(ISO, 2010). Given the A40V’s 320x240 FPA with ӨFOV of 24°x18° (FLIR, 2004, 2011),  
The lens to skin-surface distance shown ‘D’ Figure 3-6, was set to 1.30 m, 
providing a 553 mm x 412 mm coplanar field of view with instantaneous spatial 
resolution of 0.58mm2 at the skin’s surface (Arthur & Khan, 2011d; Arthur et al., 
2011b). In addition to the basic optical configuration (as shown Figure 3-6), a high 
emissivity backing mat (Figure 3-9 left) was positioned immediately beyond the ROI 
during image acquisition to create a thermal chroma-key background with known and 
emissively-uniform thermo-optical properties for all clinical TIRI’s acquired (Arthur et 
al., 2011b). This controlled and consistent background (Figure 3-10) was designed to 
introduce consistency, minimise back ground noise, and facilitate  
 
 
Figure 3-7. Optical configuration for clinical TIRI image acquisition. Where: ‘Lroi ‘ = ROI length 








Figure 3-8 Optical parameters impacting spatial resolution at ROI. ‘Lroi ‘ = ROI length, ‘D’ = Lens to 
ROI distance, ‘i’ = FPA, ‘ii’ = FPA element, ‘ƟIFOV’ = instantaneous angular FOV, ‘iii’ = lens, ‘Dmax’ = 
maximum lens-ROI distance permissible for a given IFOV at ROI surface, ‘L1’ = IFOV diameter at 
ROI surface, ‘iv’ = ROI surface. 
subsequent TIRI processing operations including: segmentation, inter-temporal 
calibration, in-ROI enhancement, and registration (Arthur et al., 2011a).    
As shown in the TIRI and histogram of Figure 3-10 (corresponding to Figure 3-9 Left), 
the thermal chroma key mat exhibits highly uniform emittance over it’s surface. Figure 
3-11 illustrates how introduction of the human ROI (as in Figure 3-9 Right) allows 
acquisition of distinctly bimodal clinical TIRI’s, enabling highly effective segmentation 
via the venerable threshold selection method (Arthur et al., 2011a; Otsu, 1979).  
The algorithm entails an exhaustive search for the threshold grey level ‘k’ that 
yields optimal efficacy in segmentation of bimodal digital image data, in cases (such as 
this) where intensity-based segmentation is meaningful to the application. Specifically, 
if a TIRI features ‘L’ different grey levels in the range [1, L], with the number  of pixels-
exhibiting grey level ‘i’ given by ‘ni’, and the total number of pixels in the TIRI given by 
N = n1 + n2 + ...nL; then the TIRI’s normalised histogram (Figure 3-12) is evaluated as if 
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Figure 3-9. Actual optical image acquisition configuration used, FLIR A40V camera mounted on 
purpose-built gantry, grey TIR chroma-key surface in FOV, spatially uniform false colour display 
on DAQ laptop, corresponding to the uniform TIR output shown (Figure 3-10 Right). Calibration 
of optical configuration and image acquisition software parameters (ThermaCAM Researcher 
Professional) using in-vivo test subject at the Australian Army Health Centre – corresponding to 







Figure 3-10: Two representations of backing mat emissive uniformity. TIRI shown left, and 
corresponding histogram shown right. 
 
 
Figure 3-11: Left; TIRI showing uniform background and variable ROI (lower legs) foreground. 
Right; corresponding 0-255 greylevel histogram of TIRI shown left, illustrating quintessential 
bimodality of the clinical data, and correspondence to false colour scale. 
In the case of the clinical TIRI data where, by design, ROI intensities are always greater 
than those of the background; pixels exhibiting levels greater than ‘k’ are classified as 
‘ROI’, with all others classified as background ‘B’, Figure 3-11. In order to identify the 
greylevel threshold that yields greatest classification efficacy ‘k*’, Otsu’s first evaluates 
the zeroth and first order cumulative moments of the TIRI’s normalised histogram, (ω 
and µ values). Firstly, the probabilities of background class ‘ωB’, and ROI class 
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Figure 3-12: TIRI histogram for threshold selection algorithm, with; truncation of vacant grey 
levels from extrema, background signal ‘B’, threshold search space ‘k’, and tissue signal ‘ROI’. 
Surface temperature of chroma key mat is kept below human euthermia to provide clear 
contrast and facilitate segmentation (width of region ‘k’ corresponds to ROI-B temperature 
difference), without causing a thermophysiological stimulus to the ROI. 
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Evaluation of those moments described in ( 3.3 ) to ( 3.5 ) allows expression of 
interclass variance ‘σ2’, as in ( 3.6 ). The greylevel ‘k’ that yields greatest interclass 
variance is identified as the optimal threshold ‘k*’, as in ( 3.7 ). This scheme follows 
Otsu’s conjecture that well thresheld classes are well separated in the greylevel 
domain, and thus, the greylevel ‘k’ that yields best class separation is identified as the 
optimum threshold level ‘k*’, as expressed in ( 3.6 ).  
 
 𝜎2 =  𝜔𝐵𝜔𝑅𝑂𝐼(𝜇𝑅𝑂𝐼 − 𝜇𝐵)
2 ( 3.6 ) 
 
 𝜎2(𝑘∗) = max
1≤𝑘<𝐿
[𝜎2(𝑘)] ( 3.7 ) 
 
As follows, this conjecture holds true with the subjective clinical TIRI dataset (Arthur 
et al., 2011a). Clinical image acquisition (and processing) protocols that facilitate 
isolation of pixels corresponding to the ROI / pathoanatomic context have great utility 
in both classifier-based and advanced physics-based modes of human TIRI. 
1.14 Atmospheric Control 
As mentioned in the previous chapter, the ambient clinical image-acquisition 
atmosphere can be characterised as: an optical medium for interacting TIR signals, a 
source of TIR noise, and a set of thermophysiological stimuli to the tissue volume of 
interest (Arthur & Khan, 2011d). As atmospheric control gives little scope for 
favourable alteration of transmittance or emittance (as pertinent to optical medium 
and noise source characterisations), atmospheric control protocols are designed for 
optimal thermophysiological effects. Although characterisation of the atmosphere as a 
physiological stimulus is considered a critical and underdeveloped aspect of clinical 





which thermoregulation is actuated almost solely by peripheral vasomotion, with 
extremely limited perspiration, no shivering, and minimal catabolic thermogenesis 
(Borten et al., 1984; Roy et al., 2006; Zaproudina et al., 2008). Recent approaches to 
identifying subjectively thermoneutral conditions via multi-node models of human 
thermoregulatory response to a wide range of steady and transient boundary 
conditions have arrived at the thermoneutral conditions shown in Table 3-1  (Arthur & 
Khan, 2011d; Fiala, Lomas, & Stohrer, 2001; Fiala et al., 2010).  
Table 3-1. Thermoneutral environmental conditions for human thermoregulatory response as 
per ANSYS CFX CFD model of flow and heat-transfer of air within a controlled indoor 
environment. Where: Tair, = ambient air temperature, Tsr = temperature of surrounding surfaces, 
Vair = ambient air velocity, Rh = relative humidity; Єw, = average spectral emissivity of 
surrounding wall surfaces, actbas = coefficient of metabolism due to physical exertion (Fiala et al., 
2001; Fiala et al., 2010). 
Tair, °C Tsr, °C Vair, m/s    Rh, %      Єwall, actbas, met 
30.0 30.0 0.05   0.4             0.93                  0.8  
 
In summary, this chapter builds on the generic infrared characterisation of the clinical 
setting provided in chapter 3 to develop specific clinical protocols for a TIRI study into 
osseous stress pathology (OSP) in the tibiae of an Australian basic trainee population. 
Detailed investigations with the Australian Defence Science and Technology 
Organisation into pathophysiology and anatomy informed specific design decisions 
surrounding optical configuration and environmental control, which culminated in a 
detailed clinical TIRI protocol. The following chapter describes how this protocol was 
implemented at the Australian Army Health Centre to evaluate the protocol in a real 












IMPLEMENTATION OF CLINICAL TIRI PROTOCOL 
CHAPTER SUMMARY 
This chapter gives a detailed account of how the TIRI protocol designed in Chapter 4 
was implemented over 3 months at an Australian Army Hospital, to evaluate 
performance of the protocol in a real clinical setting, and produce a dataset of more 
than 500 TIRI’s tracking the shins of 120 recruits through basic training. A key finding 
from this dataset was the normal TIRI profile of a healthy shin, which is an important 
baseline in any image-based diagnosis. This chapter describes the key features of a 
normal shin TIRI, and then explains how those features are consistent with lower leg 
physioanatomy. Another key finding was the high processability of the dataset, which 
is necessary in cases of abnormal TIRI profiles. This chapter shows how a standard 
medical image processing routine can be used to extract diagnostically useful 
information from TIRI data obtained via this protocol. Finally, this chapter discusses 
opportunities to improve the protocol, and the specific potential of TIRI in diagnosis 
and management of osseous stress pathology.  
 
Clinical Trial 
1.15 Implementation of Protocol 539-10 
The data collection methodology used in this three month clinical study was endorsed 
by: Curtin University Human Research Ethics Committee, the Australian Defence  
Human Research Ethics Committee, and registered with the Australian New Zealand 
Clinical Trials Registry - ACTRN12611000623998 (Arthur & Khan, 2011b; M. Khan, 
2011). Military basic trainee populations are known for high incidence of tibial stress 
fractures, due to the sudden increase in high impact physical activity experienced by 





capability goals of the DSTO (Australian Defence Science & Technology Organisation), 
the study was conducted at the ARTC (Asutralian Army Recruit Training Centre), 
Kapooka NSW. Upon arrival at the Australian Army Recruit Training Centre, three 
platoons of basic trainees consisting of 56, 48, and 43 recruits were given a 
comprehensive plain-language study briefing, and allowed 24 hours to anonymously 
deposit consent forms featuring medical questions pertinent to contraindication of 
TIRI into a sensitively located ballot box, Figure 0-1 (M. Khan, 2011).  
Ethical considerations and participant safeguards are detailed in the full 
protocols included in appendices. Consenting participants were first thermally imaged 
during their initial inoculation parade, occurring prior to their first physical training 
session. Thermal infrared images were acquired prior to administration of any 
vaccines to avoid vasoactive artifacts (Arthur et al., 2011b). In absence of data 
pertinent to optimal conditions for pre-TIRI equilibration, participants remained 
seated, clad in loose fitting gym shorts and T-shirts, without shoes or socks, for a  
 
 
Figure 0-1. Comprehensive plain-language study briefing to prospective participants with 
Defence Nurse Unit Manager present. Participants (foreground right) remove boots and socks to 





nominal 20-30 minute period, in a room with ambient conditions as listed in previous 
chapter.  
During equilibration (prior to image acquisition) each participant’s legs were 
visually photographed to screen potentially contraindicative superficial lesions. 
Following equilibration, patients lay stationary supine upon an unarticulated/flat 
LINAK OpenBus™ hospital bed, for no less than 3 minutes prior to image acquisition. 
Several 2cm thick dark grey matt-finish chroma-key mats were kept in redundancy, 
equilibrating on rotation to 20°C in an anteroom and used as a backing surface 
between the bed and each participant to prevent residual thermal artifacts from 
previous participants. An ad-hoc camera mounting system was constructed (Figure 0-1 
centre, and Figure 0-2  left) to steadily maintain steady lens to skin-surface distance 
with the optical axis normal to the patient bed.  
In absence of data concerning optimal ambient conditions for image capture, 
five wall-mounted Daikin FVXS71H ducted inverter units maintained conditions as 
close to thermoneutral as possible. Pending release of the IEC TC/SC/WG5 
specifications for medical grade thermal infrared cameras, data collection was 
performed with a FLIR A40V ThermoVisionTM TIRI camera, used in the configuration  
  
 
Figure 0-2. Implementing clinical TIRI image acquisition protocol #592-10 to acquire an anterior 
TIRI of the lower legs of an Australian Army recruit during week one of his basic training at the 





shown in Figure 0-2. The Flir A40V is based around an uncooled array of 
microbolometer infrared detectors, which can detect temperature changes as small 
each participant. Participants were thermally imaged via the same protocol on three 
further occasions during their training continuum; in conjunction with scheduled 
medical check-up parades in weeks four, seven, and nine (Arthur & Khan, 2011b; M. 
Khan, 2011).  
Any participants presenting consistently with osseous stress injury during the 
course of the study were withdrawn from physical training and subject to either MRI 
or nuclear bone scan in accordance with Australian Army SOPs. Additional TIRI’s 
acquired from these symptomatic subjects within the two hour period immediately 
prior to MRI or bone scan procedures. Both MRI and Nuclear Scintigram (aka ‘bone 
scan’) image data were de-identified before use in comparison / validation of TIRI 
data. Subjects diagnosed with ‘debilitating stress fracture’ were sent home for 6 weeks 
of convalescent leave.  
 
Table 2. Ambient clinical conditions during TIRI image acquisition (Arthur et al., 2011b).  
  Thermoneutral  Experimental Reference 
Air Temperature 30°C 28°C ± 1°C 
Vaisala HUMICAP® 
HM34 
Relative Humidity 40% 46%  ± 3% 
Vaisala HUMICAP® 
HM34 
Wall Emissivity 0.93 0.92-0.96 FLIR A40V®  




Air Velocity 0.05 m/s Minimized 
Vaisala HUMICAP® 
HM34 
Basal Metabolic Rate 0.8 Minimized N/A 
 
*Optimal thermoneutral values as calculated via the IESD-Fiala human thermoregulation 






1.16 The Normal Pretibial TIRI – Described and Explained 
Among the 474 asymptomatic thermal images obtained, were 116 complete 4-image 
longitudinal intra-subject TIRI sets taken over the full ten weeks of basic training, 
allowing longitudinal change detection of emissive profile with a view to pathological 
staging. Analysis of these asymptomatic images also allowed characterisation of a 
‘normal’ thermal topography for the asymptomatic anterior lower leg (Figure 0-3) 
with utility potential as a healthy baseline against which to compare potentially 
abnormal lower-leg TIRI’s (Arthur et al., 2011b).  
 
 
Figure 0-3. Archetypal anteroposterior view of the normal non-pathological 7.5 to 13.0 μm 
emissive profile of the lower leg, as perceived by TIRI. Left: false-colour TIRI display wherein 
colour is proportional to TIRI-inferred temperature assuming global greybody emissivity of 0.98, 
produced within FLIR ThermaCAM Researcher Professional v2.8. Right: partially-processed grey 
scale TIRI (segmented from chroma-key background and in-ROI image enhancement via 
histogram stretch), with coloured crosshairs marking the centroids of emissively distinct regions 





Table 0-3. Thermal Characteristics of the Normal Shin TIRI.  
n = 474 
Mean  Mode 
Standard Deviation 
Є = 0.98 Inter-subject Intra-subject 
Temp Max 31.0 °C 31.2 °C 0.6 °C 0.25 °C 
Temp Min 28.0 °C 28.2 °C 0.4 °C 0.11°C 
 
*Typical loci of maxima and minima indicated by the red and blue crosshairs in Figure 0-3 
respectively. 
 
As with all medical imaging modalities (whether morphological or physiological) 
knowledge of normal healthy appearance is crucial. The apparent characteristic 
features of this ‘normal / asymptomatic profile’ correspond to the thermophysiology of 
the underlying anatomy Figure 0-4. As shown Figure 0-4, it was found helpful to 
characterise the healthy TIR profile as comprised of 5 emissively distinct regions. The 
blue crosshair in Figure 0-3 right marks the centroid of the funnel-shaped proximal 
region, most commonly found to be the site of least LWIR emittance (Arthur et al., 
2011b). 
As shown Figure 0-3, this coldest blue region overlies no thermogenic anatomy, 
is distal to the thermogenic muscle compartments, and as shown Figure 0-5, features 
the thickest layer of avascular interstitial osteocutaneous tissue (≈ 3.5 mm), 
supposedly insulating / attenuating the subsurface thermal profile from the TIRI-
perceptible surface. The second row of Table 2 characterizes the average quantitative 
thermal characteristics of this region, as calculated from a dataset of 474 TIRI’s 
acquired over a period of 3 months.  
The red crosshair in Figure 0-3 marks the centroid of the almond-shaped lateral 
region, from which emittance is typically at a maximum. As shown in blue in Figure 
0-4, this lateral region overlies the compartment of the highly thermogenic tibialis 
anterior muscle. Similarly, the white crosshair Figure 0-3, and the red regions in Figure 





the distal-proximal increasing gradients of both thickness and lipid concentration in 
pretibial tissue volumes. The green crosshair in Figure 0-3  
 
Figure 0-4. Anatomic explanation of ‘normal’ shin TIRI. Left: avascular interstitial tissue volumes, 
with P-D decrease in thickness and lipid content. Centre: anterior muscle compartment (blue), 
superficial posterior compartment (red). 
 
corresponds to the area overlying an avascular osteocutaneous volume of medium 
thickness, bounded by both aforementioned thermogenic muscle compartments. 
The yellow crosshair marks the region overlying the thinnest avascular volume 
of osteocutaneous tissue, most distal to thermogenic anatomy. Figure 0-5 provides a 
magnified view of the three osteocutaneous tissue volumes excised from the cadaveric 
specimen shown Figure 0-4 Left. Although all three volumes are avascular and 
thermophysically homogeneous, and without thermogenic anatomy; there are clear 





proximal – these gradients intuitively correspond to the healthy / asymptomatic AP 




Figure 0-5. Magnified view of the three pretibial tissue volumes excised from the cadaveric 
specimen shown Figure 0-4 Left. Although all three volumes are avascular and thermophysically 
homogeneous, and without thermogenic anatomy; there are clear increases in both interstitial 
tissue thickness and lipid concentration from distal to proximal (D-P) – these gradients 
intuitively correspond to the asymptomatic AP profile shown Figure 0-3. 
 
1.17 Processability of TIRI Data  
In addition to description and explanation of the ‘normal’ TIRI shin profile, the 116 
complete four-image longitudinal intra-subject TIRI sets (taken over the full ten weeks 
of basic training) were subject to an image processing routine designed to investigate 
the feasibility of staging osseous stress pathology via change detection over time, 
Figure 0-6. The clinical TIRI data collection protocols were intentionally designed to 
facilitate this subsequent extraction of clinically useful information from image data 





highlighted in the first stage of the image processing routine shown Figure 0-6, where 
inclusion of chroma-key backing mats in the image acquisition protocol enables 
segmentation and inter-temporal calibration of image data during subsequent analysis 
stages.  
The full image processing routine applied to the data obtained with the protocol 
is described in Figure 0-6. The image processing routine was designed to include all 
the basic processing steps used in standard medical image processing, namely; 
segmentation, quantitative calibration (in this case calibration of temperature), 
enhancement of ROI, identification of interest points, helpful description of interest 
points, and finally subtraction of subsequent images in a series to reveal change over 
time. This routine is particularly suited to the tracking / staging of osseous stress 
pathology over the course of basic training, and produced results (shown Figure 0-15) 
which are consistent with clinical theory, highlighting the area directly over the tibia as 
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Figure 0-6. Image processing routine designed to explicate the feasibility of staging osseous 
stress pathology via TIRI-based temporal change detection. This routine was used to process 
four-image longitudinal data sets taken over the course of Australian Army basic training 
(Arthur et al., 2011a). 
1.17.1 Segmenting TIRI Images 
Segmentation is the process of partitioning an image into discrete sets of pixels that 
represent a specific part of the physical system being analysed. In medical imaging, 
segmentation usually involves partitioning an image into ‘the human body’ and ‘the 
background’, or partitioning discrete tissues within the imaged body part. In this 
clinical TIRI application, the TIRI image data is being segmented into ‘the human body’ 
and ‘the background’, so that subsequent image processing efforts can be focussed on 
the human body part of the image. The optical configuration and protocols used 
produced a dataset of bimodal images such as that in Figure 0-7, enabling effective 
segmentation via the threshold selection method (Arthur et al., 2011a; Otsu, 1979).  
The thresholding algorithm described in Figure 0-7was implemented in Matlab 







Figure 0-7. Left: false colour scale TIRI featuring uniform backing-mat background and variable 
ROI (lower legs) foreground. Right; corresponding 0-255 greylevel histogram regions pertinent 
to action of threshold selection algorithm upon clinical data, with; truncation of vacant grey 
levels from extrema, background signal ‘B’, threshold search space ‘k’, and tissue signal ‘ROI’.  
(equivalent to maximisation of interclass variance σ2, as in Figure 0-7 right) as inputs, 
and outputting a normalised intensity value of ‘k*’ in the range [0, 1] (Figure 0-8 
centre).  The algorithm then takes the greyscale TIRI and ‘k*’ threshold level [0, 1] as 
two inputs, assigns a greylevel of 255 (white) to all pixels of the input image exhibiting 
exceeding the threshold, assigns greylevel 0 (black) to all other pixels, then outputs the 
resulting logical class (binary) image (Figure 0-8 right). When implemented as in 
Figure 0-8, input of a greyscale TIRI yields output of binary masks corresponding to 
the ROI and background, (code in appendix A.).  
1.17.2 Time Series Image Calibration 
As described in Protocol #592-10, recruits were imaged during weeks 1, 4, 7, and 9 of 
their basic training courses. Quantitative changes in tibial pathology over time 
translate to changes in; temperature, infrared emittance, and ultimately grey level in a 
TIRI. Quantitative detection of these time series changes requires inter-image 
calibration. As mentioned, the backing mats used during clinical image acquisition 
featured uniform emissivity across their entire surface, and were maintained at 
constant temperature during all imaging sessions. Actual ‘background emittance’ (Wm-







Figure 0-8: Visualisation of ‘threshold selection’ segmentation process. Image far right showing 
typical resolution achieved in clinical TIRI’s, despite significant corona as shown in ‘False Colour 
TIRI’, far left.  
basis/ground truth for cross-time-series image calibration. Following Figure 0-7 The 
mean greylevel value ‘µB’ of each TIRI’s background region ‘B’ is readily available.  
These ‘µB’ values were used as the basis for evaluation of the global calibration offset to 
be applied to each TIRI (apart from the first in series), as illustrated Figure 0-9. 
1.17.3 In-ROI Contrast Enhancement 
During clinical image acquisition, the TIRI system is set to detect emittance in a range 
closely encompassing ROI characteristic variation, corresponding to ‘L’ different grey 
levels in the range [1’, L]. Following segmentation and subsequent masking of the 
background to a greylevel of zero; the variance of each TIRI’s histogram in a 







Figure 0-9. Intertemporal image calibration via global linear greylevel offset making all 
background regions have the same greylevel. As the backing mats have demonstrated uniform 
emissivity across their surfaces and their surface temperatures were maintained at a constant 
value throughout the study, they constitute a valid and helpful ground truth for calibration 
(Arthur et al., 2011a, 2011b). 
histogram in that set (Arthur et al., 2011a, 2011b). This fraction was then used as a 
coefficient for a linear contrast stretch over all greylevels except 0, which remains 
occupied by the masked background, Figure 0-10. Following this selective 
normalization operation, each image was subject to contrast-limited adaptive 
histogram equalization (CLAHE). The CLAHE operates on small regions in the TIRI, 
called ‘tiles’, rather than the entire image. Each tile's contrast is enhanced, such that 
the histogram of the output region approximately matches a user-defined histogram. 
The neighbouring tiles are then combined using bilinear interpolation to eliminate 
artificially induced boundaries. Contrast in homogeneous areas was limited to avoid 





1.17.1 Interest Point Identification 
The interest point identification process is a search for correspondences in discrete 
TIRI’s, as the initial phase in the registration process. The most valuable property of  
 
Figure 0-10. Illustration of selective normalisation operation for within-ROI contrast stretching 
of ‘L’ different grey levels in the range [1’, L], to occupy greylevels [1-255].  
an interest point detector is its repeatability, i.e. whether it reliably finds the same 
interest points under different viewing conditions. Given the nature of the image 
acquisition process, interest points in the 592-10 TIRI’s were detected using 
OpenSURF's variant of the SURF fast Hessian detector, with excellent illumination and 
rotation invariance (Evans, 2011). The fast Hessian reduces computational expense in 
interest point detection via box-filter approximation (Figure 0-11, right) of the 






Figure 0-12 illustrates application of the detector to a pre-processed sample 
TIRI from the 592-10 database (left), with circle-bounded interest points 
superimposed (right) (Arthur et al., 2011a). Rather than using a different measure for 
selecting the location and the scale (as in the Hessian-Laplace detector (Bay, Ess, 
Tuytelaars, & Van-Gool, 2008)), SURF uses the determinant of the Hessian for both 
for both (Bay, Ess, Tuytelaars, & Van-Gool, 2008). Given a point x = (x, y) in an image ‘I’, 
the Hessian matrix H(x, σ) in x at scale σ is defined as ( 0.1 ), Where Lxx (x, σ) is the 
convolution of the Gaussian second order derivative ( 0.2 ), of the image I at point x, 
and similarly for Lxy (x, σ) and Lyy (x, σ) (Arthur et al., 2011a). 
Rather than using a different measure for selecting the location and the scale 
(as in the Hessian-Laplace detector (Bay, Ess, Tuytelaars, & Van-Gool, 2008)), SURF 
uses the determinant of the Hessian for both. Given a point x = (x, y) in an image ‘I’, the 
Hessian matrix H(x, σ) in x at scale σ is defined as in ( 0.1 ), Where Lxx (x, σ) is the 
convolution of the Gaussian second order derivative ( 0.2 ), of the image I 
 
 
Figure 0-11 Left: discretised and cropped Gaussian second order partial derivatives in y-
direction and xy-direction, and right; 9x9 box-filter approximations of the Gaussian second order 
derivatives ( 0.2 ) where 9x9 corresponds to a σ value of 1.2, as used in processing of the 592-10 
TIRI database. The grey regions are equal to zero. Adapted from (Gossow et al., 2011). 
at point x, and similarly for Lxy (x, σ) and Lyy (x, σ) (Arthur et al., 2011a). 
 
𝐻(𝑥, 𝜎) = [
𝐿𝑥𝑥(𝑥, 𝜎) 𝐿𝑥𝑦(𝑥, 𝜎)
𝐿𝑥𝑦(𝑥, 𝜎) 𝐿𝑦𝑦(𝑥, 𝜎)










Although Gaussians are optimal for scale-space analysis, in practice they must be 
discretised and cropped (Figure 0-11 ,left), and induce aliasing upon sub-sampling of 
the resultant images, Figure 0-12 centre. The 9 × 9 box filters in Figure 0-11 far right, 
are approximations of Gaussian second order derivatives, with σ = 1.2, which  
 
 
Figure 0-12. Fast Hessian interest point detector. Left; lower limb following pre-processing, 
Centre; staged convolution through to interest point detection, Right; superimposition of 
detected interest points on the original TIRI. Interest points lie at centre of circular regions from 
which their descriptors are subsequently extracted; green radial lines define reference abscissa 
from which the descriptor wavelets operate, Figure 0-13. (Arthur et al., 2011a). 
corresponds to the spatial resolution used in processing of the 592-10 images. Dxx, 
Dyy, and Dxy denote approximations.  Weights applied to the rectangular regions are 
kept simple for computational efficiency, using the 0.9 derived in ( 0.3 ), to balance the 
relative weights in the expression for the Hessian’s determinant,     








= 0.912 ≃ 0.9 ( 0.3 ) 
   
 
 det(𝐻𝑎𝑝𝑝𝑟𝑜𝑥) = 𝐷𝑥𝑥𝐷𝑦𝑦 − (0.9𝐷𝑥𝑦)
2 ( 0.4 ) 
 
1.17.2 Interest Point Characterisation 
Once detected, interest points are characterized via local distribution, as classified by 
Haar wavelets, Figure 0-13. A sub-region’s descriptor represents the nature of the 
underlying intensity pattern. In Figure 0-13 left, in the case of a homogeneous region, 
all values are relatively low. Figure 0-13 centre; in presence of frequencies in the x 
direction, the value of Idxl is high, whilst dx, dy, and |dy| remain low. Where intensity 
increases gradually in the x direction, both values dx and Idxl are high. Hence, each 
sub-region has a four-dimensional descriptor vector v for its underlying intensity 
structure. This results in a descriptor vector for all 4 x 4 sub-regions of length 64.  
The wavelet responses are invariant to a bias in illumination (offset). Invariance 
to contrast (a scale factor) is achieved by turning the descriptor into a unit vector (Bay 
et al., 2008). When applied to the TIRI's, the descriptor's performance improved 
significantly following segmentation and contrast enhancement (Arthur et al., 2011a). 
Once interest points in temporally contiguous images are characterized, those of most 
statistical similarity are assigned to each other in pairs, as shown in Figure 0-14 left.  
 𝑽 = ( ∑𝑑𝑥 ,∑|𝑑𝑥| ,∑𝑑𝑦,∑|𝑑𝑦|) ( 0.5 ) 







Figure 0-13. Illustration of the way the descriptor characterises each interest point based upon 
four properties (dx, |dx|, dy, and |dy|). These dimensions are based upon Haar Wavelet sampling. 
 
1.17.3 Image Differencing 
Once interest points have been identified and characterized, they can be used as 
control points in registration, as in Figure 0-14. As shown in Figure 0-14 right 
'wk_l_warp', the algorithm provides an excellent warp with minimal distortion to the 
original. Following such a high fidelity registration, it is meaningful to perform 
subtractive change detection, as in Figure 0-14 below. Figure 0-14 shows consistency 
in the site of most emissive change over time; namely, the anteromedial aspect of the 
tibia. This localization of change conforms to intuitive agreement with current 
understanding of osseous stress pathophysiology (Goodman et al., 1985; Pascoe et al., 
2008; Phillipson & Parker, 2009; Rae, 2010), and the thermophysiology of the 







Figure 0-14. OpenSURF-based generation of point correspondences and resultant warp of 'wk_I' 






Figure 0-15. Longitudinal difference imaging in a progressing pathological subject (wherein 
white indicates site of change, black indicates consistency over time), showing a consistent site of 
emissive change overlying the anteromedial aspect of the tibia (Arthur et al., 2011a). 
In summary, this chapter described how the TIRI protocol designed in Chapter 4 was 
implemented at the Australian Army Training Centre, introduced and explained the 
normal TIRI profile of a healthy shin, and demonstrated extraction of diagnostic 
information from TIRI data via standard medical image processing operations. 
Although this study demonstrates significant potential for TIRI as an initial screening 
tool for osseous stress pathology, it also highlights the need to explore deeper analyses 
of clinical TIRI data that have potential to provide high-specificity clinical decision 
support. The following chapter explores how analysis of clinical TIRI data can be used 
to determine the depth of subsurface heat sources, such as osseous stress fractures 























HEAT SOURCE DEPTH DETERMINATION 
CHAPTER SUMMARY 
This chapter demonstrates successful practical application of a technique proposed by 
(Wang et al, 2011) for recovering the depth of a focal heat source within the body from 
analysis of a TIRI of the overlying skin surface. The first section of this chapter explains 
the theoretical basis for this technique, and the second accounts successful use of the 
technique to recover heat source depths from 30 TIRI’s obtained in the clinical study 
described in the previous chapter. In demonstrating this ‘quantitative clinical TIRI 
analysis with greater diagnostic specificity than screening’, this chapter satisfies; the 
need identified in the previous chapter, and a key prerequisite for medical community 
adoption of TIRI identified by the U.S. Defence TIRI Technology Transfer Study. 
4. Determining Depth of Tissue Abnormalities 
The clinical significance of heat source depth determination via a non-invasive non-
ionising technique like TIRI can be best appreciated in context of oncology, where the  
 
Figure 4-1. The heat source depth determination problem - determine source depth d from skin 





depth of a focal heat source in the form of a tumour is an established predictor of; 
primary malignancy, metastasis, appropriateness of resection, probability of upstaging, 
tumour control performance, and general prognosis. All of these measures provide 
critical decision support in management of a pathology that seriously affects millions 
of patients each year. In addition to biopsy, this tumour depth determination is 
currently performed with MRI, X-Ray CT, and ultrasound; all imaging modalities for 
which TIRI would be a rapid, low cost, non-contact, and non-ionising alternative.  
As represented in Figure 4-1, TIRI-based heat source depth determination 
(HSDD) is a 3D heat conduction boundary value problem, in which the temperature 
distribution across the skin surface is the key boundary value that can be found via 
TIRI, and the problem is to solve for the heat source depth given the heat transfer 
properties of the source and interstitial tissues. The mathematical tool that enables 
solution of 3D heat conduction problems is a delta function, which represents the heat 
source as an idealised point in space, Figure 2. A Dirac delta function is a pulse of 




[𝐻(𝑡 + 𝑎) − 𝐻(𝑡 − 𝑎)] ( 4.1 ) 
 







[𝐻(𝑡 + 𝑎) − 𝐻(𝑡 − 𝑎)] ( 4.2 ) 
 
 
Figure 2. Dirac Delta Function - a pulse of infinite magnitude and infinitely short duration. This 





In standard terms ( 1.2 ) is not a function, but a distribution, where a distribution is a 
generalisation of a function’s concepts. By taking the Fourier transform of the pulse, it 
can be shown that the Fourier transform of the Delta function is identically 1. By 
putting δ(t) formally through the convolution it can be seen that the delta function 
behaves like the identity under convolution.  
When we use the Dirac delta function to represent the source as a point combined 
with a practical shape function, the surface temperature distribution captured in the 
TIRI is considered a convolution of the temperature distribution generated by the 
point source, with, the practical shape function. Accordingly, the temperature 
distribution captured within the TIRI must be deconvoluted via Fourier deconvolution 
scheme, before the source depth can be found from it via a graphical method exploiting 
the Fourier transform identity suggested by Wang et al, as demonstrated and 
explained through detailed examples using real clinical TIRI data below.  
1.18 Graphic Determination of Heat Source Depth 
Development of this algorithm for software implementation and practical application 
involves the following steps: 
1. Define an expression for the temperature distribution seen by TIRI on the skin’s 
surface as a function of: the temperature of a subsurface heat source that is a 
single point within the tissue, and, the heat transfer properties of the tissue 
between the heat-source and the skin’s surface. 
2. Enhance the expression to describe surface temperature distribution as the 
result of a subsurface heat source with realistic shape and size, as opposed to an 
idealised point in space. 
3. Incorporate a Fourier deconvolution scheme to circumvent the need for a-priori 
heat source geometry information (Wang et al, 2011). 
4. Implement the algorithm in Matlab for evaluation of its performance with real 






As mentioned in the description of bioheat transfer through human tissues in chapter 
3, heat transfer from subsurface sources to the skin’s outer surface may be modelled 






+ ∇(−𝑘∇𝑡) = 𝑄𝑣  ( 4.3 ) 
 
Where Φ, c, and k, are the density, heat capacity, and thermal conductivity tensor of 
the tissue, respectively; t is the temperature of tissue, T is the time variable, and Qv is 
the sub-surface heat source (stress fracture / tumour). Using a spherical co-ordinate 
system, and assuming steady-state heat transfer, isotropic conductivity and a point 
heat source, ( 4.3 ) can be expressed as in ( 4.4 ): 
 
 











𝑄 ∙ 𝛿(𝑟) ( 4.4 ) 
 
where δ(r) is the Dirac delta function of the heat source’s radius, which is used to 
represent the sub-surface heat source as an idealized point mass. When r ≠ 0,( 4.4 ) 








) = 0 ( 4.5 ) 
 
Solution to ( 4.5 ) for t looks like ( 4.6 ), where C1 and C2 are constants (evaluated 
below)We now think of the heat source as a small sphere ‘Ω’ with radius 𝜀 (𝜀 → 0+), 





+ 𝐶2 ( 4.6 ) 
of ( 4.4 ) over V (volume of the heat source), and substitute a value of t (temperature at 
a point on the skin’s surface obtained from ( 4.6 ), gives ( 4.7 ) where dV is the 






Figure 4-3.   Representing the heat source as an infinitesimal red sphere ‘Ω’ located at point ‘O’. 
sphere Ω, and Σ is the outer boundary of the closed domain Ω, rearranged to make C1 
the subject, as in Error! Reference source not found.: 
 
 




∙ 𝑑𝑆 = 4𝜋𝐶1 =  − 
𝑄
𝑘
 ( 4.7 ) 
 
 
𝐶1 = − 
𝑄
4𝜋𝑘
 ( 4.8 ) 
 
To then evaluate the other constant (C2), the hottest point on the skin’s surface is 
assumed to lie directly above the centroid of the heat source. This hottest point on the 
surface is labeled O’ as shown in Figure 4-3.  Assuming the temperature of the sub-
surface heat source at point O is tm, from ( 4.6 ) gives ( 4.9 ),  
 
 
𝐶2 = 𝑡𝑚 − 
𝑄
4𝜋𝑘𝑑
 ( 4.9 ) 
   
 
 
𝑡 = 𝑡𝑚 − 
𝑄(𝑟 − 𝑑)
4𝜋𝑘𝑑𝑟






Figure 4-4.  Introducing ' ρ ', the distance from a given point on the surface to the hottest point 
within the ROI. The hottest point on the surface is referred to as O'. 
Using ( 4.10 ) the temperature at any given point on the skin’s surface is calculated as 
a function of distance from the hottest point on the surface, which in the case of a 
simple spherical sub-surface heat source and uniform interstitial tissue will occur at O’ 
in the centre of the ROI. The distance of a given point on the surface from point O’ is 
expressed as a new parameter called ρ, as shown Figure 4-4. In order to now extract 
heat source depth ‘d’ from the surface temperature distribution, the new function          





 ( 4.11 ) 
 
When this new function f(ρ) is plotted using parameter values in the range relevant to   
human physiology, it takes a shape similar to that shown in Figure 4-5. 
As ρ appears as ρ2 in ( 4.11 ), it is helpful to notice from Figure 4-6, the Pythagorean 
relationship of ρ to depth d, as ρ2 = r2 – d2.  Substituting ( 4.10 ) into ( 4.11 ), gives 
( 4.12 ): 
 
𝑓(𝜌) =  
4𝜋𝑘𝑑
𝑄







Figure 4-5. A plot showing the shape of f(ρ), equation ( 4.11 ), as a function of ‘rho’, the distance of 









From ( 4.12 ) it is possible to obtain the limit and value for  f(ρ) at ρ = 0 and ρ = d, via            




𝑓(𝜌) = 8𝜋𝑘𝑑3 ( 4.13 ) 
 
 𝑓(𝜌)⌋𝜌=𝑑 = 4𝜋𝑘𝑑
3(2 + √2) ( 4.14 ) 
 








𝑓(𝜌) ≈ 𝟏. 𝟕𝟎𝟕 lim
𝜌→0
𝑓(𝜌) ( 4.15 ) 
   
The significance of equation ( 4.15 ) lies in the constant 1.707 coefficient value shown 
in bold.  This constant of 1.707 is key to the graphical method for determining source 
depth from plots of  f(ρ) like Figure 4-5, namely, that the value of f(ρ) when ρ=0 is 
always approximately 1.707 times smaller than the value of f(ρ) at ρ=d, where d is the 
depth of the heat source. Exploiting this 1:1.707 relationship is the crux of the graphic 
depth determination method, which is done as follows: 
1. Plot f(ρ) vs ρ (as shown Figure 4-5), and identify the value of f(ρ) at ρ=0, as 
shown in Figure 4-7. 
2. Multiply the value f(ρ) at ρ=0 by a factor of 1.707, to find the point on the Y axis 
from which to draw a horizontal line, also shown in Figure 4-7.  
3. Draw a horizontal line from this new point on the Y axis, in the positive x 
direction, until the line intersects curve f(ρ), Figure 4-9. 
4. At this point where the horizontal line meets the curve, ρ = d (as shown Figure 
4-8) draw a vertical line down from the intersection of the horizontal line and 








Figure 4-7. Steps 1 and 2 of the graphic heat source depth determination method – identifying 
the value of f(ρ) at ρ=0, and multiplying that value by 1.707 to find the point on the Y axis from 
which to draw a horizontal line across to the curve f(ρ). 
 
 
Figure 4-8. Step 3 of the graphic heat source depth determination method – drawing a horizontal 
line from the point on the Y axis at which f(ρ) = 1.707 x [f(ρ) at ρ=0], across to the point on curve 






Figure 4-9. Step 4 of the graphic heat source depth determination method – drawing a vertical 
line down from the intersection of the horizontal line and curve f(ρ) to the X axis, to identify the 
value of ρ at the point where ρ = d, and therefore finding d. 
1.19 Deconvolution of Surface Temperature Distribution  
As mentioned above, in clinical cases where a real heat source is involved (as opposed 
to the theoretical point source considered hitherto) the stress fracture or tumor (for 
example) will have a non-zero shape and size. The thermal distribution pattern on the 
skin’s surface that results from this real heat source can be termed ‘g’, and expressed 
as shown in ( 4.16 ): 
 
 𝑔 = 𝑡 ⨂ ℎ + ℰ ( 4.16 ) 
 
Where ‘t’ is the surface temperature resulting from a point source, as given by ( 4.10 ), 
‘h’ is the shape function of the source (Figure 4-10), ‘ε’ is the noise, and ‘⨂’ is the 
convolution operator. To make the aforementioned graphic method useful in real 
clinical applications, it is necessary to deconvolute expression ( 4.16 ).  
 In cases where the shape ‘h’ of the heat source is known and well defined, it is 





method to determine source depth. In practical clinical TIRI, however, the shape of the 
source ‘h’ will usually be unknown – requiring deconvolution via blind Fourier 
transform. The critical property of Fourier transforms that makes this possible, is the 
fact that ‘the Fourier transform of the convolution of two functions is equal to the 
product of their individual transforms’. In the absence of noise, the Fourier transform 
representation of ( 4.16 ) is as shown in ( 4.17 ): 
 
 𝐺(𝑢) = 𝑇(𝑢)𝐻(𝑢) ( 4.17 ) 
 
Where the uppercase letters in ( 4.17 ) represent the Fourier transforms of the 
corresponding functions. The basic blind deconvolution scheme can be written as 
shown in ( 4.18 ) to ( 4.25 ), Where the superscript ‘k’ denotes the number of 
iterations, ‘abs’ denotes the absolute value function, ‘medfilt’ is the median filtering 
operator, and ‘F’ and ‘F-1‘ denote the  Fourier transform and inverse Fourier 
transform, respectively. Equation ( 4.21 ) ensures production of a shape function, and 
( 4.25 ) uses a median filter to reduce the effects of noise. 
 
 
Figure 4-10. Representation of heat source shape function ‘h’. In the case of clinical TIRI, the 
exact shape of the heat source will probably be unknown, but will have significant impact upon 
the fidelity of depth recovery from surface TIRI data – hence the need for deconvolution of the 





 𝑇(𝑘)(𝑢) = 𝐹𝑡(𝑘)(𝜌) ( 4.18 ) 
 
 𝐻(𝑘)(𝑢) = 𝐺(𝑢)/𝑇(𝑘)(𝑢) ( 4.19 ) 
 






{ℎ(𝑘)(𝜌) + 𝑎𝑏𝑠[ℎ(𝑘)(𝜌)]} ( 4.21 ) 
 
 𝐻(𝑘)(𝑢) = 𝐹ℎ(𝑘)(𝜌) ( 4.22 ) 
 
 𝑇(𝑘)(𝑢) = 𝐺(𝑢)/𝐻(𝑘)(𝑢) ( 4.23 ) 
 






𝑚𝑒𝑑𝑓𝑖𝑙𝑡{𝑡(𝑘)(𝜌) + 𝑎𝑏𝑠[𝑡(𝑘)(𝜌)]} ( 4.25 ) 
 
This is an iterative scheme so it is repeated a number of times until two functions with 
the convolution are found. One is the shape function and the other is the point source 
temperature.  
Implementation of this algorithm requires substitution of a nonnegative-valued 
initial estimate of temperature distribution t(0)(ρ) into deconvolution scheme ( 4.18 ) 
to  ( 4.25 ), with successive iterations until two positive functions with the required 
convolution g (ρ) have been found. Figure 4-11 illustrates the effect of the blind 
deconvolution scheme upon the shape of the temperature distribution that the source 
depth determination algorithm considers – where skin surface temperature is 






Figure 4-11. Effect of the blind deconvolution scheme upon the temperature distribution 
considered across the skin’s surface, with temperature as a function of rho (cm). 
1.20 Computer Implementation 
The heat source depth determination algorithm described in the previous section was 
implemented in MATLAB, using the code shown in appendices. The code translates 
input values of TIRI-measured surface temperature profiles into output graphs of ρ2 / 
(tm – t) as a function of ρ, from which heat source depth may be recovered via the 
graphic method. For implementation, it is necessary to supply the code with enough 
information to estimate an initial temperature distribution t(0)(ρ) to initiate the 
iterative deconvolution loop from ( 4.18 ) to ( 4.25 ): 
 
%Assign initialising parameter value estimates 
   
tmeas=32.4;   %TIRI-Inferred Surface Temperature 
ts=36;      %Assumed Point Source Temperature (blood-perfused periosteum)     
d1=0.3;     %Point Source Depth 
d2=0.4;     %Extended Source Depth 
Q1=1;       %Magnitude of Point Source     
Q2=0;       %Magnitude of Extended Source     





rho=-3:0.001:3;  %Define range of surface distances 








Extended Source Distribution 
 
 
The loop then repeats until two positive functions with the required convolution g(ρ) 
have been found, remembering that ‘g’ represents the heat distribution data measured 
on the skin’s surface by clinical TIRI, as in ( 4.16 ).  
 
for i=[1:No_Iterations];%Blind Deconvolution loop 
     
   T=fft(Point_Source); %Convert point source to Fourier domain 
    
   G=fft(Extended_Source); %Convert extended source to Fourier domain 
        
   H=G./T; %Define shape function in Fourier domain 
     
   h=ifft(H); %Convert shape function to temperature domain 
     
   h=(1/2).*((h)+abs(h)); %Check that shape function is positive 
     
   H=fft(h); %Convert shape function back to temperature domain 
     
   T=G./H; %Define next value of point source temp in Fourier 
     
   Point_Source=ifft(T); %Convert next value of point source into 
temperature domain 
     




ts=max(Point_Source); %Find max value of new temp distribution 
  
fp_deconv=(rho.^2./(ts-Point_Source)); %Define f(p) for new temperature 
distribution 
 
The Matlab implementation was then tasked to recover the depth of the dominant heat 
source within the tibial tissue volume examined during the clinical study (the blood-





shows the heat source depth situation relevant to the clinical study and associated TIRI 
data. The left side of the figure shows cadaveric excision of the pretibial 
thickness/depth of tissue overlying the distal third of the tibia, through which heat 
must pass from the blood-perfused periosteum to reach the skin’s surface.  
The right side of the figure is a schematic of the blood-perfused periosteum 
(red) in relation to the tibial cortex (grey). During dissection of a cadaveric specimen 
that was representative of the sample population examined in the clinical study, the 
thickness of tissue overlying the tibial periosteum, which corresponds to the heat 
source depth to be retrieved from the clinical TIRI data obtained, varied from 
approximately 1mm at the distal third of the tibia, to approximately 3 mm at the 
proximal third. A sample of 10 TIRI’s containing 30 tibial ROI’s (3 per tibia) was 




Figure 4-12. The heat source depth situation relevant to the clinical study. Left: cadaveric 
excision of the 1mm thick pretibial tissue (ROI_3) overlying the distal third of the tibia, through 
which heat must pass from the blood-perfused periosteum to reach the skin’s outer surface seen 
by TIRI. Right: schematic of the blood-perfused periosteum (red) in relation to the tibial cortex 





The TIRI’s selected correspond to healthy participants who did not develop any 
symptoms during the study. The TIRI’s were imported into FLIR Systems’ proprietary 
software environment for analysis, Thermovision Professional V2.8. As the Matlab 
implementation of the heat source depth determination algorithm requires skin 
surface temperature as the input from which to recover heat source depth, the 
‘spotmeter’ tool was used to extract the surface temperature distributions from the 
three ROI’s within each of the 30 radiometrically-calibrated TIRI’s, as shown in Figure 
4-13.  
As detailed above, these ROI’s were selected to provide representative thermal 
characterisation from the thermophysiologically-distinct thirds of the tibiae. The 
absolute surface temperature distributions obtained from the analyses shown in 
Figure 4-13 are given in Figure 4-14. 
 
 
Figure 4-13. Radiometric TIRI, being analysed within FLIR Thermovision Professional v2.8. The 
temperature values obtained via this software were used as the surface temperature inputs to 
the Matlab heat source depth determination code. It is these temperatures (1-3) that are 







Figure 4-14. Surface temperature distributions across the ROI’s shown in Figure 4-15. R3 (blue), 
R2 (green), and R1 (Red) correspond to the distal, medial, and proximal ROI’s shown in Figure 
4-15, respectively. The mean absolute temperature for each ROI is shown top right of each 
distribution. 
Following extraction of surface temperature distributions from the clinical TIRI’s, via 
the method shown in Figure 4-13 and Figure 4-16, the mean absolute temperature 
from each ROI distribution was obtained, and entered into the Matlab code as the 
initial temperature distribution t(0)(ρ) to initiate the iterative deconvolution loop from 
( 4.18 ) to ( 4.25 ). Figure 4-15 shows the resulting graph of t (ρ) corresponding to the 
proximal ROI_2, shown in green in the centre of Figure 4-13 and Figure 4-14.  
From inspection of Figure 4-15, it is clear that the code produces a surface 
temperature distribution with the expected shape and features corresponding to a 
spherical heat source as described in Figure 4-10. Although this shape function is not 
an accurate representation of a distributed heat source like the periosteum would be 
in the real case, the model still produces acceptable results for determination of source 
depth.Figure 4-16 is a plot of ρ2 / (tm – t) as a function of ρ, corresponding to central 
ROI_2, marked green in the clinical TIRI of Figure 4-13.  
The depth of the subsurface heat source (periosteum) leading to the 
temperature distribution across ROI_2 in Figure 4-13, may be recovered from Figure 
4-16 via application of the graphic method. The red rectangle extending out to the right 






Figure 4-15. Skin surface temperature as a function of rho (distance from point on the skin’s 
surface overlying the centroid of the heat source), representing the temperature distribution 
extracted from ROI_2, shown green and centred in TIRI Figure 4-13 and Figure 4-14. The green 
curve represents the blue distribution (extended source) adjusted via the deconvolution scheme. 
should be noted that the green spike at rho = 0 is an artefact of the Dirac delta function 
within ( 4.4 ), and is not driven by a constitutive property of the physical heat transfer 
system. Figure 4-18 illustrates application of the graphic method to correctly 
determine the depth of the heat source beneath the skin surface of ROI_2 in Figure 
4-13. As shown, f (ρ) intersects the y axis at ‘A’, where Y = 0.1206. As per the graphic 
method detailed above, horizontal line BC is then drawn, such that OB = 1.707 OA = 
0.2109, and ‘C’ lies on curve f (ρ). Vertical line CD is then drawn vertically down to 
intersect the X axis at D, indicating the depth of the heat source, namely 0.2109 cm.   
The small photograph inset bottom right of Figure 4-18 shows an actual pretibial 
tissue volume excised from a proximal tibial ROI  corresponding to ROI_2 in in Figure 
4-13, and analysed here. As can be seen from inspection of the photograph, the surface 
of the periosteum (heat source) is approximately 2mm beneath the skin’s surface, in 
excellent agreement with the heat source depth value obtained via the graphic method 
above. Figure 4-17 and Figure 4-19 illustrate successful use of the technique to recover 






Figure 4-16. Plot of ρ2 / (tm – t) as a function of ρ, from which the depth of heat source beneath 
ROI_2 may be recovered via the graphic method.  
 
Figure 4-17. Successful recovery of heat source depth (≈ 3mm) from TIRI of tibial ROI_1. 
Photograph inset bottom right shows the actual tissue depth involved (also ≈ 3mm), taken 
during dissection of a population-representative pretibial tissue volume. Note that the 
interstitial tissue beneath ROI_1 is a lot more fatty than the tissue in ROI_2, so a lesser thermal 






Figure 4-18. Successful heat source depth determination on real clinical TIRI data of tibial ROI_2. 
The source depth recovered by the graphic method is indicated where line CD intercepts the X 
axis at point ‘D’, corresponding to a source depth of approximately 0.2 cm. The photograph inset 
bottom right shows the actual tissue depth involved (also ≈ 2mm), taken during dissection of a 






Figure 4-19. Successful recovery of heat source depth (≈ 1mm) from TIRI of tibial ROI_3. The 
photograph inset bottom right shows the actual tissue depth involved (also ≈ 3mm), taken 
during dissection of a population-representative pretibial tissue volume. Note that the 
interstitial tissue beneath ROI_3 is a lot less fatty than the tissue in ROI_1 and ROI_2, so a greater 
thermal conductivity value should be applied. 
1.21 Results & Discussion 
This heat source depth determination technique was applied to a total of 30 tibial 
ROI’s, taken from 10 TIRI’s obtained during the aforementioned clinical study. Table 
4-1 and Figure 4-21 to Figure 4-26 summarise the heat source depth recovery results 
and the surface temperature data used to produce them. Because mean ROI 
temperature (as determined by clinical TIRI, assuming small ρ) was the sole parameter 
varied in study of this depth recovery technique, evaluation of the technique’s efficacy 
is based upon consideration of whether the depth values obtained made sense when 
compared to depths obtained via dissection of the actual tissue volume in a 
representative human cadaver (Figure 4-20) – rather than sensitivity analysis of the 
technique to constitutive elements of the heat transfer model and deconvolution 








Figure 4-20. Reminder of the objective – to determine heat source depth from TIRI of the surface. 
Shown are the three ROI’s and associated tissue depths excised from the cadaveric specimen 
shown Figure 0-4 Left. Although all three volumes are avascular and thermophysically 
homogeneous, and without thermogenic anatomy; there are clear increases in both interstitial 
tissue thickness and lipid concentration from distal to proximal (D-P). 
Overall, this study found that when real clinical TIRI-obtained pretibial skin surface 
temperature distributions are entered into the aforementioned heat transfer model 
that features physiologically-representative heat transfer parameter values, the heat 
source depth determination technique described above (graphic method plus blind 
deconvolution) produces heat source depth values that are consistent with the 
relevant thermoanatomy, as determined by investigative dissection - Table 4-1, and 
Figure 4-20. This claim assumes that: the primary heat source driving the temperature 
distribution seen by TIRI across the pretibial skin’s surface is the blood-perfused tibial 
periosteum, and that the cadaver used for investigative dissection of the actual tissue 
depths corresponding to each tibial ROI was representative of the population studied 





Table 4-1. Skin surface temperature values and heat source depths recovered from TIRI’s of 
tibial ROI’s during clinical study. *TIRI # 1 corresponds to Figure 4-13 used in the example above. 
*Recovered depths should be compared to actual tissue sections shown in Figure 4-20. 
TIRI # ROI_# 
Surface Temperature [K] Recovered 





1 305 305.9 305.4 3.1 
2 304.8 305.7 305.2 2.1 
3 304.8 305.7 305.2 1.1 
2 
1 305.2 306.1 305.6 2.9 
2 304.9 305.7 305.6 1.9 
3 304.8 305.9 305.3 1.1 
3 
1 304.9 305.9 305.5 3.1 
2 305.4 306.1 305.7 1.9 
3 305.2 306.2 305.6 0.9 
4 
1 304.9 305.9 305.4 3.1 
2 304.6 305.9 305.3 2.1 
3 304.9 306 305.3 1.1 
5 
1 304.7 305.7 304.9 3.2 
2 304.5 305.4 305 2.2 
3 304.4 305.1 304.8 1.2 
6 
1 304.8 305.6 305.1 3.1 
2 304.9 305.7 305 2.2 
3 305.1 305.3 305 1.2 
7 
1 305.8 306.3 306.1 2.8 
2 305.5 306.3 306 1.8 
3 304.8 305.9 305.4 1.1 
8 
1 304.8 306 305.3 3.1 
2 304.8 305.7 305.2 2.1 
3 305.2 305.9 305.5 1.1 
9 
1 305.2 306 305.4 3.1 
2 304.7 305.7 305.2 2.1 
3 305 305.7 305.2 1.1 
10 
1 305.2 306.1 305.6 2.9 
2 305.7 306.3 306 1.8 






Figure 4-21. Distribution of mean surface temperatures across tibial ROI_1 acquired from TIRI 
analysis of a sample of 10 clinical study participants. The fact that all participants presented with 
temperatures inside a tight range (S.D. = 0.26) suggests that ROI_1 temperatures found outside of 
this range could be indicative of dysfunction. 
 
 
Figure 4-22. Distribution of mean surface temperatures across tibial ROI_2 acquired from TIRI 
analysis of a sample of 10 clinical study participants. All participants presented with ROI_2 
temperatures inside a tight range (S.D. = 0.36) suggesting that ROI_2 temperatures found outside 
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Figure 4-23. Distribution of mean surface temperatures across tibial ROI_3 acquired from TIRI 
analysis of a sample of 10 clinical study participants. All participants presented with ROI_3 
temperatures inside a tight range (S.D. = 0.22) suggesting that ROI_2 temperatures found outside 




Figure 4-24. Distribution of heat source depths obtained from analysis of all ROI_1 TIRI’s. Mean 
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Figure 4-25. Distribution of heat source depths obtained from analysis of all ROI_2 TIRI’s. Mean 





Figure 4-26. Distribution of heat source depths obtained from analysis of all ROI_3 TIRI’s. Mean 











1.80 - 1.89 1.90 - 1.99 2.00 - 2.09 2.10 - 2.19 2.20 - 2.29
Frequency
Source Depth Determined [mm]
Depth Data - Tibial ROI_2
S.D. = 0.15










0.80 - 0.89 0.90 - 0.99 1.00 - 1.09 1.10 - 1.19 1.20 - 1.29
Frequency
Source Depth Determined [mm]
Depth Data - Tibial ROI_3
S.D. = 0.08





These encouraging preliminary results warrant further efforts to test and improve the 
validity and robustness of the approach and HSDD technique, i.e. devising ways to 
make the technique fail, and learning from the nature of those failures how the 
technique can be made more robust. For example, a tissue phantom of known heat 
transfer properties and dimensions, and with an embedded controllable heat source, 
could be used to test the robustness of the technique’s ability to distinguish a ‘smaller 
hotter deeper’ source from a ‘larger and cooler but shallower’ source, that produces a 
similar surface temperature distribution. Although the current algorithm does protect 
against this type of failure by allowing the researcher to prescribe initial parameter 
value estimates, a more physically valid approach would be preferable. This type of 
work using tissue phantoms with embedded know heat sources also gives opportunity 
for development of improved thermometric MRI sequences, which could provide an 
invaluable validation modality for ongoing TIRI studies. 
Another area recommended for further investigation is the sensitivity of the 
model to the aforementioned initial parameter estimates. The fact that the code 
recovers source depths consistent with anatomic expectations (ranging from 1 to 3 
mm) for all ROI’s in all participants, despite surface temperatures being extremely 
similar for all ROI’s in all participants (S.D. for entire sample = 0.31, ranging from 
304.8K – 306.1K) suggests that the current implementation of the algorithm may be 
too sensitive to initial parameter estimates (Arthur & Khan, 2013). Future 
implementations should strive to ensure that clinically obtained surface temperature 
distributions have significantly greater influence over final depth results than operator 
determined initial parameter estimates.  
Although the stark difference in fat content between the different tibial ROI’s is 
apparent from inspection of the dissection photos inset in Figure 4-20, the lack of 
variation in the range of human tissue thermal conductivity values reported in the 
literature (~ 0.45 - 0.55) suggests there is little performance / robustness to be gained 
from efforts to use ROI-specific thermal conductivity values in future implementations 
of the algorithm. 
The successful demonstration of the clinical protocols developed and promising 





TIRI’s potential in clinical decision support. Although encouraging, the specificity and 
therefore clinical utility of TIRI as used in the clinical study described is limited by the 
absence of: a gold standard thermal imaging modality for validation of results 
obtained, and corresponding high-fidelity bioheat transfer models. As the biosignal 
detected by TIRI (thermal emittance, wm-2) is multivariate in nature, a step-change 
advancement in specificity and clinical utility critically depends on high-fidelity 
quantitative deconvolution of human thermal infrared emittance – which is driven by 
our understanding of the nature of human emissivity. 
Progressive definition of human thermophysical properties, and development 
of TIRI-based thermometric capability, requires successive iterations of empirical 
measurement and validation from an appropriate benchmarking modality. Moreover, 
the information attainable by TIRI alone is insufficient for generation of inverse 
bioheat transfer solutions with sufficient fidelity for the demanding clinical 
applications that stand to gain from TIRI’s fulfilment of its potential. Without infusion 
of thermometric information from an appropriate complementary modality, cross-
constraint of the inverse problem and generation of solutions with clinically acceptable 
fidelity will remain intractable.  
Accordingly, a logical next step toward the advancement of TIRI for clinical 
applications is a highly controlled laboratory study to provide a deep understanding 
and characterisation of the nature of human skin emissivity. In turn, this deeper 
understanding will enable us to design better image acquisition protocols. In summary, 
this chapter has demonstrated successful TIRI-based HSDD on real clinical TIRI data, 
and motivated the goal of the following chapter, which entails a detailed laboratory-
based investigation to further our understanding of human skin emissivity as the 












REASSESSING THE EMISSIVITY MODEL 
CHAPTER SUMMARY 
This chapter investigates whether the conventional model of regime-independent 
emissivity is adequate for use in the more temperature-critical next generation 
applications such as heat source depth determination. This chapter describes 
experiments conducted in a controlled environment at FLIR Systems Calibration 
Laboratory which showed that human skin emissivity varies significantly across 
clinically-relevant regimes of wavelength and skin type (Arthur & Khan, 2013). These 
findings motivate a change of practice toward use of regime-specific emissivity models 
in clinical TIRI applications where absolute temperature accuracy is critical. 
5. Emissivity in TIRI 
Temperature ‘T’ [K] is a measure of the energy with which the constituent particles of 
a material perform a certain type of vibration, specifically, the type of vibration that 
gives rise to emittance of infrared waves of energy. The Stefan-Boltzmann law Error! 
Reference source not found.) describes an idealised relationship between these two 
related energies; the energy of the particle vibrations ‘T’ [K], and the energy of the 







Figure 5-1. Stefan-Boltzmann law relating temperature ‘T’ (energy of particle vibrations) and 
emittance ‘j’ (energy of TIR waves). Image modified from (Spring et al, 2006).  
 
Figure 5-2: Idealised relationship between the temperature and emittance of a perfect 
‘blackbody’ radiator, according to the Stefan-Boltzmann law, Error! Reference source not found.. 
‘σ’ is Boltzmann’s constant 5.67×10-8 [Wm-2K-4], derived from the idealised physics of 
thermal radiation.  
Clinical TIRI systems measure ‘j’ directly, then use the version of the Stefan-
Boltzmann law shown ( 0.1 ) which has been non-idealised by inclusion of the 
emissivity coefficient ‘Є’, to calculate tissue temperature ‘T’ [K]. Emissivity is defined as 
‘the ratio of the energy radiated from a real material ‘j’ (Wm-2) to that which would be 
radiated from an idealised ‘blackbody’ material (Error! Reference source not found.) 
under the same regime of temperature, waveband and viewing conditions. Emissivity 
is expressed as a dimensionless number with a value between 0.0 and 1.0, where 1.0 
represents the idealised emission described by the idealised law in Error! Reference 
source not found.. 
 
 










As the definition implies, regime-dependency is one of the defining characteristics of 
emissivity, and real non-idealised materials like human tissues can and do exhibit a 
variety of different emissivities under different regimes of temperature, wavelength, 
and surface condition. Figure 0-7 illustrates the regime-dependency of a real and 
idealised objects emissivity in context of the wavelength parameter of a TIRI regime.  
 
Figure 5-3: Emissivity of real, black, and grey bodies, as a function of wavelength. 
In Figure 0-7, the fluctuating red line illustrates the non-linear variability of a real 
materials emissivity as a function of wavelength, on the clinically-relevant µm scale. 
Emissivity also varies as a function of multiple other variables which make up a TIRI 
regime. The key implication of emissivity being multivariate and non-linear, is that 
emissivity values to be used in ( 0.1 ) as part of a TIRI application must be empirically 
measured in the regime of the intended TIRI application, rather than predicted by a 
mechanistic model.  
Conversely, the blackbody emissivity described by the straight black line in 
crossing all wavelength regimes along the top of Figure 0-7 was derived from the 
mechanistic model described in Figure 5-1 and Figure 5-2. The important difference is 
that the blackbody model relies upon idealised assumptions of thermodynamic 
equilibrium and no net flow of energy, which allow it to define a useful baseline from 
which the emissivities of real materials can be defined, and provide a framework for 





Figure 0-7 also illustrates the ‘grey body’ model of emissivity, in which a 
constant emissivity value is used to approximate the real emissivity of a real material 
over a finite waveband. This grey body model is the emissivity model most commonly 
used in applied TIRI, including clinical TIRI hitherto. Because emissivity measurement 
requires a controlled environment and specialised equipment, it is not always possible  
 
Figure 5-4. The benefit of knowing a materials emissivity – elevates TIRI from qualitative 
emittance mapping (left), to far more useful absolute temperature mapping (right). 
or practical to measure the real emissivity of the specific ROI before each TIRI is 
acquired in an applied setting. Accordingly, the emissivity values that get used in 
applied TIRI tend to come from a look-up table, having previously been measured in a 
controlled environment under an application-relevant regime of TIRI conditions. 
Although TIRI without emissivity has use in certain screening-type applications for 
which absolute thermometric accuracy is not critical, the quantification capability that 
comes with accurate emissivity knowledge allows TIRI to realise its significant 
potential in far more clinical applications, Figure 5-4. 
1.22 The Conventional Emissivity Model in Clinical TIRI 
This section describes the conventional model of emissivity used in clinical TIRI 
hitherto, and explains why it may not be adequate for use in advanced clinical 





critical. The conventional model of emissivity use in clinical TIRI can be summarised as 
‘a regime-independent greybody model with a value of 0.98’. Although this model has 
been applied across variations in all regime parameters, the most frequently and 
significantly varied are waveband (MWIR vs LWIR), and surface condition (i.e. skin 
type from on anatomic location to another).  
 
Figure 5-5. Conventional emissivity model - regime-independent greybody value of 0.98. 
This conventional model has use in applications where precise mapping of tissue 
temperature were not critical, such as mass screening for febrile temperature profiles 
within crowds of people at airports during the recent SARS and avian flu pandemics. 
An isolated departure from this conventional model was explored during the DARPA 
HID (Human Identification at Distance) program (DARPA, 2000-2003), in which a 
model of selective emissivity was integrated as a surface boundary condition into a 
more comprehensive bioheat transfer model of human skin, with significant 
transmissivity in the most superficial layers, and significant absorptivity in the deepest 







Figure 5-6. The two leading bioheat transfer models of human skin featuring the conventional 
regime-independent skin emissivity model at (L, 0) with all subsurface heat transfer considered 
conductive and convective, as in (Çetingül & Herman, 2010b), (b) Selective emissivity and low 
index of refraction ‘n’ at the(L, 0), significant transmissivity in superficial tissue and absorptivity 
(α) in the deepest tissue layer, as in (DARPA, 2000-2003). Figure (Arthur & Khan, 2013). 
The potential inadequacy / limitation of this conventional model can be explained in 
context of TIRI-guided thermal ablation therapy, which has been identified as one of 
TIRI’s most promising next generation medical applications of the heat source depth 
determination algorithm demonstrated in the previous chapter (Oley et al., 2009). 
Thermal ablation therapy is a technique for inducing coagulation necrosis (cell death) 
within cancerous tumours by precise application of heat with a needle-like applicator. 
Figure 5-7 illustrates thermal ablation therapy in terms of the delicately temperature-
sensitive cellular processes involved.  
 The role of a TIRI system in a thermal ablation procedure would be to allow the 
surgeon to observe the increasing temperature of the tumour gradually increasing in 
real time, making it possible to deliver a far more controlled and accurate heat, whilst 







Figure 5-7. Thermal ablation - reproduced with permission from (Chu & Dupuy, 2014). 
5°C in absolute tissue temperature measurement (≥50°C vs 41-45°C) can make the 
difference between successful induction of coagulation necrosis in a malignant cell 
cluster, and mere induction of sublethal damage which leaves the patient at risk of 
further potentially fatal metastasis. 
 Thermal ablation is just one example among many clinical applications in which 
the physiological significance of a specific absolute temperature makes emissivity 
critical, such as; cancer diagnostics, intraoperative haemodynamic monitoring, and 
affective computing (Çetingül & Herman, 2010c; de Weerd, 2010b; M. Khan et al., 
2006; Ng & Acharya, 2009). Accordingly, evaluation of the conventional models 
adequacy for next generation temperature-critical applications requires controlled 





1.23 Experimental Design 
This section documents the process of designing experiments to accurately measure 
any variations in the emissivity of human skin ROI’s that may occur as a result of 
clinically-relevant changes in TIRI regime. The most clinically-relevant changes in TIRI 
regime come from changes in the parameters of ‘imaging waveband’ and ‘ROI location’.  
 
 
Figure 5-8. Clinically-relevant TIRI regimes across which skin emissivity will be measured. 
Due to currently available IR detector technology and associated camera specifications, 
clinical TIRI can be expected to occur within one of two waveband regimes for the 
foreseeable future, namely; MWIR (~ 3-5µm), or LWIR (~ 8-13 µm). Accordingly, the 
waveband parameter will be varied between these to create two clinically-relevant 
classes of TIRI regimes in which human skin emissivity can be measured, Figure 5-8. 
Emittance measurement in regimes 1 and 2 (MWIR) will be performed with a 
via FLIR SC660 TIRI camera, featuring a 640 x 480 array of uncooled microbolometer 
IR detectors, an NETD < 30mK, and an IFOV of 0.65 mRad (FLIR, 2009b).  Emissions 
within the 7.5 – 13.0 µm waveband were measured via FLIR 550, featuring a 320 x 240 
FPA of Stirling cooled platinum-silicide IR detector elements, NETD < 30 mK, and an 





cameras were subject to two-point radiometric cavity-blackbody calibration at 298K 
and 318K (Arthur & Khan, 2013). Detailed manufacturers datasheets for both cameras 
can be found in the appendices. 
 
 
Figure 5-9. ROI’s for MWIR and LWIR emissivity measurement. Pretibial ROI’s (left) correspond 
to ADHREC clinical study protocol. Facial ROI’s (right) chosen to represent a cross-section of skin 
types among the FTFP’s used in automated affect classification (M. Khan et al., 2006).  
With potential for even more variation than the waveband parameter is the anatomic 
location of the ROI. In context of TIRI regimes, a change in ROI location most 
importantly constitutes a change in radiating surface material (skin) properties, and to 
a lesser extent in ROI surface temperature range. In order to meaningfully capture 
emissivity variance due to ROI location and remain within the scope of this study, it 
was decided to measure the emissivity of two anatomically-distinct skin ROI’s, creating 
two further classes of TIRI regime, Figure 5-9. These ROIs were identified given the 
significant differences in emissivity-relevant surface properties of skin at these two 
locations, the principal investigators’ deep experience in handling the idiosyncrasies of 





Collectively, measurements obtained within each of the 4 regimes in Figure 5-8 
should provide sufficient insight to the variability of human skin emissivity across a 
representative cross-section of clinically-relevant TIRI scenarios to indicate whether 
or not the conventional regime independent emissivity model is adequate for use in 
temperature-critical applications going forward. As previously mentioned, accurate 
measurement of emissivity requires a suitably controllable environment, and 
specialised equipment.  
Moreover, there are two leading techniques for emissivity measurement in the 
literature, namely; measuring reflectivity and invoking Kirchhoff’s law, or by acquiring 
a TIRI of the ROI next to a radiation source with known emissivity and temperature 
and directly comparing their emittance. Each of these techniques have advantages and 
disadvantages. The reflectance technique requires assumption of thermal equilibrium 
in the ROI. This assumption allows application of Kirchhoff’s law ( 5.11 ), stating that 
the emissivity of a body (ελTψ) in thermal equilibrium is equal to its absorptivity (αλTψ), 
Figure 5-10. 
 
 𝜆𝜓𝑇 = 𝛼𝜆𝜓𝑇  ( 5.2 ) 
  
Considering irradiation of the ROI with emittance of known wave properties from a  
controlled synthetic source (Sanchez-Marin, 2010); this irradiance must be reflected  
(ρ), absorbed (α), or transmitted (τ) as described in ( 5.3 ): 
 
 𝜌𝜆𝜓𝑇  + 𝛼𝜆𝜓𝑇  + 𝜏𝜆𝜓𝑇 = 1      
𝑦𝑖𝑒𝑙𝑑𝑠
→          𝛼𝜆𝜓𝑇 = 1 − 𝜌𝜆𝜓𝑇  − 𝜏𝜆𝜓𝑇 ( 5.3 ) 
 
Substituting ( 7.1 ) into ( 5.3 ), allows expression of emissivity (Ԑ) in terms of 
reflectivity (ρ) and transmissivity (τ), ( 5.4 ) and Figure 5-10: 
 
 𝜆𝜓𝑇 = 1 −  𝜌𝜆𝜓𝑇  − 𝜏𝜆𝜓𝑇 ( 5.4 ) 
 
 𝜏𝜆𝜓𝑇 = 0        
𝑦𝑖𝑒𝑙𝑑𝑠
→            𝜆𝜓𝑇 = 1 −  𝜌𝜆𝜓𝑇 






Assuming zero transmissivity in the ROI, then gives emissivity in terms of reflectivity 
(ρ) as in Figure 5-11:Considering clinical TIRI of a human ROI in absence of the 
aforementioned applied irradiance, the total TIR flux incident upon the array of 
infrared detectors inside the TIRI camera ‘Φ0‘ is a combination of: emittance from the 
human ROI ‘jROI’, direct irradiation by the ambient atmosphere  Φatm, and indirect 
atmospheric irradiance via reflection from the ROI ρΦatm, as in Figure 5-13: 
 
 ∅0 =  𝑗𝑅𝑂𝐼 + ∅𝑎𝑡𝑚+ 𝜌∅𝑎𝑡𝑚 ( 5.6 ) 
   
 
 
Figure 5-10. Relationship of reflection (ρ), absorption (α), and transmission (τ) to irradiance (Φ), 
applicable to the L0 air-skin interface in the radiative bioheat transfer models shown Figure 5-6. 
Following introduction of the aforementioned synthetic irradiance ‘ΦL’, the total 
irradiance of the FPA may be given by ( 5.7 ): 
 
 ∅1 = 𝑗𝑅𝑂𝐼 + ∅𝑎𝑡𝑚+ 𝜌∅𝑎𝑡𝑚  + 𝜌∅𝐿 ( 5.7 ) 
 
Subtraction of ( 5.6 ) from ( 5.6 ) gives the reflectivity of the ROI in terms of flux values 







∅1 − ∅0 =  𝑃∅𝐿       
𝑦𝑖𝑒𝑙𝑑𝑠
→           𝜌 =  
∅1− ∅0
∅𝐿
 ( 5.8 ) 
 
Substituting ( 5.8 ) back into ( 5.5 ) then gives emissivity (Ԑ) in terms of these readily 
measurable and known infrared flux values, as in ( 5.9 ): 
 
 
𝜆𝜓𝑇 = 1 − 
∅1− ∅0
∅𝐿
 ( 5.9 ) 
 
  
Figure 5-11. Flir Systems Calibration Laboratory, Melbourne Australia. Rigid lens-object distance 
gantry among a series of greybody emittance sources with controllable surface temperature. 
Despite the non-contact benefits of the reflectance technique, the need to assume zero 
transmissivity in the ROI is undesirable given the model proposed in Figure 5-6b.  
Emissivity measurement via the greybody comparison technique requires no such 
assumption, and is preferred by our research partners at FLIR Systems Calibration 
Laboratory, Figure 5-11. The greybody comparison technique involves the following 





1. The ROI is placed next to a synthetic greybody radiation source which has 
known calibrated emissivity (≈1.0) and controllable surface temperature. 
2. ROI surface temperature is measured with a calibrated contact thermometer. 
3. Greybody temperature is set to be equal to ROI surface temperature. 
4. A single TIRI capturing emittance from both the greybody and ROI is acquired. 
5. Because intensity differences between ROI and greybody pixels are entirely 
due to emissivity difference, and the emissivity of the greybody is known, 
emissivity of the ROI is easily recovered. 
 
 
Figure 5-12. Setup for  emissivity measurement via simultaneous measurement of emittance 
from the ROI and a source with known emissivity and temperature (Arthur & Khan, 2013). 
Figure 5-12 illustrates the experimental setup for emissivity measurement via the 
greybody comparison technique. The skin ROI is represented by the white rectangle 
shown bottom right, and temperature and emissivity of the skin ROI are represented 
by Troi and Єroi, respectively. The product of Troi and Єroi  is the thermal infrared 





radiation source with known emissivity and controllable temperature is represented 
by the dark grey rectangle adjacent to the skin ROI shown upper right, and the 
temperature and emissivity of the greybody are represented by Tgb and Єgb, 
respectively.  
At the time of image acquisition, greybody temperature (Tgb) ROI temperature 
(Troi) and are equal. The temperature of and emittance from any sources in the lab 
other than the ROI and the synthetic greybody are collectively represented by Trefl and 
Wrefl. The blue region in the centre of Error! Reference source not found. represents 
the ambient image acquisition atmosphere, with τ representing % transmittance, 
which is the % of MWIR/LWIR emittance that is not absorbed by the molecules in the 
atmosphere and can pass through the atmosphere over short distances.   
A contact probe (Figure 5-13) was constructed for optimal stand-alone 
measurements of Tsk (skin surface temperature) and Tbb (blackbody temperature). A  
 
 
Figure 5-13. Purpose built contact probe for measuring ROI and greybody surface temperature  
in greybody comparison technique for emissivity measurement (Arthur & Khan, 2013). 
25-mm diameter circular M1024222 GE-Health skin contact pad was used to affix the 
sensor head to the skin and blackbody surface ROIs. The M1024222 contact pad 
features hypoallergenic non-irritating non-sensitising adhesive, light flexible 3mm 





potential for introduction of TIR artefacts due to application and removal of the 
contact pad was evaluated and dismissed via visual inspection of ROI TIRIs taken pre 
and post -pad application.  
 A type-T, 32 standard wire gauge PVC-coated Dural thermocouple was used as 
the embedded temperature sensor. A Super-MCJ Omega Engineering thermocouple-to-
analogue connector was used to relay the measured surface temperatures to an Agilent 
U1272 a digital multimeter, giving readings to 0.1K. The human subject was allowed a 
nominal 30-minute period to equilibrate to ambient laboratory conditions at seated 
rest prior to measurement. During said period, facial and tibial ROIs were left 
uncovered, and periodically observed under real-time LWIR TIRI to qualitatively 
assess emissive stability.  
Following equilibration, contact Tsk measurements were made at the subjective 
ROI. The contact probe was then removed from the skin ROI and applied to the surface 
of the greybody emitter; Tbb was then adjusted until achieving Tbb = Tsk . The ambient 
atmospheric conditions were entered manually into the camera to facilitate accurate 
compensation via online proprietary FLIR algorithms, and scene emittance was then 
measured in both MWIR and LWIR bands.  
In accordance with thermoneutral conditions prescribed by the cybernetic 
‘IESD-Fiala ANSYS CFX’ model of human thermoregulation in controlled indoor 
environments, ambient laboratory air temperature, humidity, and velocity were  
maintained at 294 (± 1.0) K, 46 (± 1.0) %, and < 0.1ms-1, and monitored via Vaisala 
HUMICAP® HMP155 and DANTEC FiberFlow®, respectively. Immediately prior to 
image acquisition, emissivity and surface temperature values of the surrounding wall 
and ceiling surfaces were recorded at 0.92-0.96 and 293-296K respectively, as 
calculated via 2-point calibrated FLIR SC660 TIRI camera. 
1.24 Results: Regime Dependence of Skin Emissivity  
This section presents the results of experiments to measure the regime-dependent 
emissivity of human skin in the form of TIRI image data and energy distribution 





each of the four regimes. The histograms show each ROI’s emittance in terms of a non-
calibrated unit called Object Signal (OS) which is proprietary to FLIR Systems. Because 
OS is proportional to the amount of energy incident upon the detectors of the 
particular TIRI camera being used, it allows for direct comparative imaging with 
calibrated greybody sources in any given waveband, and creates a level playing field 
for this type of experiment without being influenced by the idiosyncrasies of a 
particular TIRI cameras responsivity (FLIR, 2004, 2009a, 2009b).  
Because MWIR TIRI was performed using a camera with photonic platinum 
silicide (PtSi) detectors, the MWIR Object signal shown in the histograms below was 
linear with respect to incident MWIR photons per m2 of detector per second, as shown 
( 5.10 ). Similarly, LWIR OS values obtained via the vanadium oxide microbolometers 
are linear with respect to incident Wm-2. Integration of ( 5.10 ) or ( 5.11 ) with respect 
to wavelength gives the total energy emitted from the ROI at known surface 








































Figure 14. TIRI acquired in regime 1 to measure MWIR emissivity of facial skin ROI’s. 
Figure 14 shows a TIRI of 3.6-5.0µm emittance from a 309K greybody with emissivity 
of 0.99 and a 309K facial ROI with emissivity to be determined. The difference in pixel 
intensity between the greybody and skin ROI is obvious, and corresponds to an 
emissivity difference of 0.05 (= 0.99 - 0.94), but energy differences ~100 OS, as shown 
in Figure 5-16 to Figure 5-18.  This contrasts with the 7.5 – 13.0 µm LWIR situation in 
Figure 5-15, characterised by a less obvious brightness contrast from greybody to 
facial ROI, and ΔOS values between LWIR greybody and facial energy distributions on 
the order of  ~10, as visible in Figure 5-19 to Figure 5-21.  
 






Figure 5-16. MWIR Emittance Histogram from FTFP_7 and an equal temperature greybody. 
 
Figure 5-17. MWIR Emittance Histogram from FTFP_34 and an equal temperature greybody. 
 






Figure 5-19. LWIR Emittance Histogram from FTFP_7 and an equal temperature greybody. 
 
Figure 5-20. LWIR Emittance Histogram from FTFP_34 and an equal temperature greybody. 
 






Figure 5-22. TIRI acquired in regime 3 to measure MWIR emissivity of Pre-Tibial skin ROI’s 
The indistinguishable pixel intensities the ROI’s and greybody in Figure 5-22 suggest 
that the MWIR emissivity of the tibial ROI’s is extremely close to the known 0.99 
emissivity of the controllable greybody source. Moreover, the emittance histograms in 
figures Figure 5-24, Figure 5-25, and Figure 5-26 are almost completely overlapping. 
The LWIR emissivity however is characterised by clear intensity difference in Figure 
5-23, and clear ΔOS separation in the emittance distributions shown in 







Figure 5-23. TIRI acquired in regime 4 to measure LWIR emissivity of Pre-tibial skin ROI’s.  
 






Figure 5-25. MWIR Emittance Histogram from TIB_3-6 and an equal temperature greybody. 
 
Figure 5-26. MWIR Emittance Histogram from TIB_5-8 and an equal temperature greybody. 
Figure 5-27 LWIR Emittance Histogram  from TIB_1-4 and an equal temperature greybody. 
 










Table 5-1. Experimentally determined emissivity (Ԑ) values. 
Spectral ROI Temp Contact [K] Temp TIRI [K]  SD    Ԑ  [0, 1] 
          
FTFP_07 MWIR 308.5 308.4 0.2 0.98 
FTFP_07 LWIR 308.5 308.1 0.2 0.96 
FTFP_34 MWIR 309 308.5 0.3 0.94 
FTFP_34 LWIR 309 308.1 0.2 0.92 
FTFP_66 MWIR 310.1 308.5 0.2 0.85 
FTFP_66 LWIR 310.1 308.3 0.3 0.87 
TIB_1-4 MWIR 305.8 305.6 0.1 0.98 
TIB_1-4 LWIR 305.8 304.1 0.1 0.83 
TIB_3-6 MWIR 305 305 0.1 0.99 
TIB_3-6 LWIR 305 303.8 0.1 0.86 
TIB_5-8 MWIR 304.8 304.8 0.2 0.99 







To boost the statistical power of  
 
 
Table 5-1’s clinically relevant insights into emissivity variation, radiometric analyses 
were performed upon a random sample of 10 clinical TIRI data sets taken from the 
#592-10 data base acquired at the Australian Army Medical Centre, Figure 5-30 
(Arthur et al., 2011b). For each image, skin surface temperature and contact-inferred 
emissivity corresponding to three left-leg ROIs (TIB_1–4, TIB_3–6, and TIB_5–8) were 
calculated as per the mean energy and ROI emissivity equations  ( 5.13 ) and ( 7.13 )  
proposed in (DARPA, 2000-2003; L. B. Wolff et al., 2005). In ( 5.13 ) and ( 7.13 ), 
ēs_LWIR represents the mean LWIR energy detected as emittance from the ROI, ēBBTs 
represents blackbody energy at skin temperature, T̄s is  
Table 5-2. Contact-measured skin surface temperature and emissivity at 3 tibial ROI’s. 
Participant # Tibial ROI  TIRI Temperature [K] Emissivity (ε) 
1 
TIB_1-4 LWIR 303.4 0.94 
TIB_3-6 LWIR 301.6 0.92 
TIB_5-8 LWIR 300.4 0.91 
2 
TIB_1-4 LWIR 305.1 0.95 
TIB_3-6 LWIR 302.3 0.93 
TIB_5-8 LWIR 301.2 0.92 
3 
TIB_1-4 LWIR 302.3 0.93 
TIB_3-6 LWIR 301.6 0.92 
TIB_5-8 LWIR 300.7 0.91 
4 
TIB_1-4 LWIR 304.1 0.94 
TIB_3-6 LWIR 303.2 0.94 
TIB_5-8 LWIR 302.7 0.93 
5 
TIB_1-4 LWIR 304.1 0.94 
TIB_3-6 LWIR 302.8 0.93 






TIB_1-4 LWIR 302.8 0.93 
TIB_3-6 LWIR 302 0.92 
TIB_5-8 LWIR 301.3 0.92 
7 
TIB_1-4 LWIR 303.1 0.93 
TIB_3-6 LWIR 302.6 0.93 
TIB_5-8 LWIR 302 0.92 
8 
TIB_1-4 LWIR 302.9 0.93 
TIB_3-6 LWIR 302.1 0.93 
TIB_5-8 LWIR 301.3 0.92 
9 
TIB_1-4 LWIR 303.3 0.94 
TIB_3-6 LWIR 302.5 0.93 
TIB_5-8 LWIR 301.4 0.92 
10 
TIB_1-4 LWIR 304.7 0.95 
TIB_3-6 LWIR 303 0.93 
TIB_5-8 LWIR 302.1 0.93 
  
Figure 5-30. (a) Laboratory data, (b) clinical validation data - radiometrically calibrated 
blackbody-temperature TIRI’s of 12 recruits used in the validation. For clinical data, total 
emissive energy and contact-inferred emissivity at TIB_1–4, TIB_3–6, and TIB_5–8 were 
calculated with the method reported in (DARPA, 2000-2003; L. B. Wolff et al., 2005). 
average skin temperature in the ROI, TBBT̄s means blackbody temperature, Q 
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    [𝑤𝑚2𝜇𝑚−1𝑠𝑟−1] ( 5.15 ) 
 
Wherein C1 and C2 represent constants in Planck’s spectral energy distribution with 
respective values of 0.59992 x 108 W·µm4 / (m2 ·sr), and 14387.69 µm·K.  
1.25 Discussion and Conclusions 
As evident in Table 5-2, the calculated ROI emissivity values differ significantly from the 
conventionally accepted ‘close to blackbody’ or ‘≈ 0.98’ emissivity of human skin. The previous 
calculations are aligned with the generalization of Planck’s equation proposed for the LWIR 
region in (L. B. Wolff et al., 2005) which assumes C2/λT << 1, and expresses emissive power (eλb) 
as in ( 5.15 ). As illustrated in the TIRI’s and emittance histograms above, and summarised in  
 
 
Table 5-1, the emissivity of human skin varies considerably across clinically relevant 
regimes of both regimes of waveband and anatomic ROI location. 
Interestingly, it can be seen that both MWIR and LWIR emissivity values 
obtained via this greybody comparison technique applied at the forehead (FTFP 7) and 
skin region overlying orbicularis oculi (FTFP 34) agree with those in the literature, as 
might be expected given that the forehead constitutes a conventional anatomic site for 
clinical contact thermometry (Arthur & Khan, 2013). It is also interesting to note that 
emissivity values obtained for non-traditional ROIs differ significantly from those in 





reflective media display less wavelength dependence, with FTFP_66 (Orbicularis Oris) 
being consistently less emissive then other FTFP’s in both the MWIR and LWIR spectra, 
ranging from 0.971 to 0.99 (Sanchez-Marin, 2010; Togawa & Saito, 1994).  
These observations reinforce the need for calculation of regime-specific 
emissivity values for use in critical clinical applications. It is also interesting to note the 
consistency of the wavelength-dependence of tibial emissivity with; all tibial MWIR 
values within 0.98-0.99, and LWIR values from 0.83-85. In contrast, less wavelength 
dependence was observed at facial ROI’s, with FTFP_66 being consistently less 
emissive then other FTFP’s in both the MWIR and LWIR. 
In terms of waveband-specific considerations, the far greater energy densities 
involved in the MWIR than the LWIR should be considered when designing the 
thresholds for regime-specific emissivity values. This significant difference in energy 
density (and perhaps regime size sensitivity) can be noticed from inspection of the 
absolute OS (object signal) values along the x axes of the emittance histograms above. 
To quantify the clinical significance of the emissivity variations discovered at FLIR 
Systems Calibration Laboratory, one can consider the case of pretibial emissivity in the  
7.5-13µm LWIR region as in Figure 5-31. A TIRI Illustrating emissivity - the ratio of the 
energy radiated from a blackbody (left, circular) to a human skin ROI (right, shin) at 
the same temperature (32°C) and wavelength (LWIR, 7.5-13µm) and under the same 
viewing conditions. This ROI has an emissivity of 0.83. In application context of TIRI 
for monitoring of an oncological thermal ablation procedure, use of the conventional 
model of a 0.98 emissivity value instead of the empirically determined 0.83, translates 
into a 16% difference in the tissue temperature displayed to the surgeon, which in the 
case of a 50°C target temperature equates to about  ±8°C. If the tumour only reaches 
42°C, the cells remain active and harmful to the patient (Figure 5-7), and if the tumour 
is heated to 58°C there will be unnecessary damage to healthy tissue surrounding the 
tumour (Figure 5-7).   
As the goal of this chapter was to investigate whether the conventional model of 
regime-independent emissivity is adequate for use in more temperature-critical next 
generation, the findings motivate a change of practice toward use of regime-specific 





critical. Moreover, it is recommended that the transition toward this new practice 
involve accurate measurement of emissivity at strategic anatomic ROI locations, which 
are likely to be imaged on many occasions in context of specific clinical TIRI 
applications. Finally, it is recommended that the scope of this investigation be 
extended to include measurements of the emissivity of internal tissues, as applicable to 
open surgical applications. 
 
 
Figure 5-31. A TIRI Illustrating emissivity - the ratio of the energy radiated from a blackbody 
(left, circular) to a human skin ROI (right, shin) at the same temperature (32°C) and wavelength 
(LWIR, 7.5-13µm) and under the same viewing conditions. This ROI has an emissivity of 0.83.  
CHAPTER 8 
KEY FINDINGS & RECOMMENDATIONS 
CHAPTER SUMMARY 
This chapter discusses the main findings from this thesis work and explains their 
implications for the future of clinical TIRI. Topics discussed include; clinical protocols, 
heat source depth determination, and emissivity models. By demonstrating the benefit 
of objective clinical protocols, this thesis motivates change of practise in both research 
and application, and expands the scope of clinical TIRI to now include applications 
requiring the greater specificity that objective protocols afford. By objectively defining 





for TIRI-based management of osseous stress injury, and provides precedent to 
investigate the usefulness of TIRI in management of similarly superficial thermo-active 
pathologies.  
By demonstrating successful TIRI-based heat source depth determination, this 
work motivates further research to rigorously evaluate TIRI’s potential as a 
replacement for existing clinical depth determination tasks, such as biopsy-based 
tumour depth determination. By demonstrating that human skin emissivity varies 
significantly across clinically-relevant regimes of wavelength and skin type (Arthur & 
Khan, 2013), this thesis motivates change of practice toward the use of regime-specific 
emissivity models in all clinical TIRI applications where absolute quantitative accuracy 
is critical. In addition to discussing the key implications of the aforementioned 
findings, this chapter also provides specific recommendations for next steps in clinical 





1.26 Clinical Protocols 
This work demonstrated an objective approach to the development of clinical TIRI 
protocols, and also demonstrated the benefit of using those protocols over a three 
month clinical study. Like TIRI, the established medical imaging modalities (MRI, X-
Ray, etc.) essentially rely on their ability to detect delicate waveform attenuations in 
order to build useful images. Unlike TIRI however, the established modalities now 
benefit from being used under strict clinical protocols inside purpose built image 
acquisition facilities designed to maximise signal to noise ratio. In MRI for example, 
significant resources are invested in purpose-built MRI suites that feature; active 
vibration damping, magnetic and acoustic shielding, temperature and humidity 





been judged on the basis of data acquired by stand-alone TIRI cameras used without 
proper protocols, in uncontrolled clinical environments. 
 
 
Figure 32. Key elements and variables in the infrared clinical setting that must be accounted for 
in clinical protocols  i) TIRI camera, ii) ambient atmosphere as an optical medium and noise 
source, and iii) human tissue under investigation (Arthur & Khan, 2011d). 
Clinical protocols for TIRI image acquisition are now well recognised by the clinical 
TIRI research community as a prerequisite for objective evaluation of TIRI’s usefulness 
in medicine. Figure 32 provides a simple layout of the clinical setting in terms of the 
infrared elements that should be considered and accounted for in any objective clinical 
TIRI protocol. Future clinical TIRI studies can use this framework as a starting point 
for the design of any clinical or laboratory-based TIRI study to ensure a complete 
picture of all the controlled and uncontrolled variables involved. As demonstrated in 
this thesis work in specific context of osseous stress pathology, clinical studies 





protocols deliver TIRI data containing significantly more diagnostic information that is 
readily extractable via standard image processing operations. 
In addition to showing that development and use of objective clinical protocols 
should be adopted as standard practice in clinical TIRI from now onwards, another 
outcome of the protocol aspect of this thesis work is the expanded scope of clinical 
TIRI applications. Objective clinical protocols expand the scope of clinical TIRI 
applications because they make it possible to achieve greater specificity (accuracy, 
precision, reliability, repeatability), and therefore make it feasible to investigate TIRI’s 
usefulness in applications that were previously ruled out due to seemingly 
unachievable specificity requirements.  
An example of a high-potential clinical application that might only receive 
competitive research and development funding when evaluated in context of an 
objective clinical protocol is ‘heat source depth determination’, as applicable to 
cancerous tumours. In tumour depth determination, TIRI has to accurately calculate an 
absolute quantitative parameter value that will directly influence the choice of 
treatment for a patient with a life threatening disease. Applications characterised by 
objective quantitative decision support are those in which TIRI can realise its fullest 
potential as a clinical tool.  
Among TIRI’s quantitative decision support applications, those involving 
significant amounts of image processing particularly stand to gain from protocols 
designed with the image processing component in mind from the outset. An example of 






Figure 33. The clinical protocol for investigation of TIRI in stress fracture diagnosis included use 
of a ‘chroma key’ background surface to facilitate subsequent image processing operations like 
segmentation of the measured signal into backing surface ‘B’ and region of interest ‘ROI’, and and 
also facilitated quantitative absolute temperature calibration. 
chroma key technique incorporated into the clinical protocol for investigation of TIRI’s 
application in stress fracture diagnosis with the Australian Army, Figure 33. The 
foresight to incorporate a chroma key background surface into the protocol (a mat of 
uniform and known emissivity and temperature placed beneath the patients’ legs) 
facilitated subsequent segmentation and quantitative calibration of the image data 
obtained. Protocols incorporating strategic features that consider the entire data 
processing and diagnostic decision making context from the outset can make or break 
a clinical trial that forms the basis for evaluation of TIRI’s usefulness in a particular 
application.  
In addition to highlighting the benefit of foresight in protocol design, the 
protocol aspect of this work also demonstrated the value of early thermal 
characterisation of the relevant anatomy, physiology, and pathology. In the stress 
fracture study with the Australian Army, the efforts made to understand and 
characterise the thermoanatomy and thermophysiology of the lower limb in context of 






Figure 34. Anatomic explanation of ‘normal’ shin TIRI. Left: avascular interstitial tissue volumes, 
with P-D (proximo-distal) decrease in tissue thickness and lipid content. Centre: anterior muscle 
compartment (blue), superficial posterior compartment (red). 
application of the protocol through the three month clinical trial at the Australian 
Army Hospital, and also during subsequent data analysis at Curtin University and Flir 
Systems Calibration Laboratory. This thermal understanding of the relevant anatomy, 
physiology, and pathology had a positive impact on all aspects of the study design, 
including clinical hardware, environmental control parameters and even image 
processing sequences. A particularly helpful exercise enabled by this a priori thermal 
characterisation work was prediction of how healthy and pathological pretibial tissues 
would likely present in a TIRI image.  In studies like this one which investigate brand 
new clinical applications of TIRI, defining what the tissue looks like to TIRI in both 
healthy and unhealthy states is a critical goal, that a thermal understanding of the 





In summary, clinical TIRI has enormous potential as a diagnostic decision 
support tool, and its usefulness in any given application should only be evaluated on 
the basis of data collected under objectively developed protocols. This work describes 
an approach to development of such clinical TIRI protocols that ensures the critical 
issues are considered to an appropriate level of rigour, Figure 32, Figure 34. Protocols 
should be designed strategically, considering the physio-anatomic context and ultimate 
diagnostic decision from the very outset. Protocols should never lose sight of the 
ultimate goal which is to support a treatment decision, and that ultimate purpose 
should remain front of mind throughout the design and implementation of any clinical 






















1.27 Heat Source Depth Determination 
As detailed in Chapter 6, TIRI can be used to successfully determine the depth of focal 
heat sources within human tissues (Figure 35). This section discusses the key technical 
challenges for development of TIRI-based HSDD (heat source depth determination), 
and suggests future research work to overcome them. This section also discusses the 
case for making tumour depth determination a target application for ongoing research, 
and outlines key steps along the technology roadmap from the current ‘proof of 
concept’ stage to useful clinical application. Among the possible applications of TIRI-
based HSDD, tumour depth determination stands out as one of the most technically 
feasible and clinically impactful. 
The technical feasibility of TIRI tumour depth determination stems from the 
fact that tumours are ideal heat sources, naturally occurring as focal, highly metabolic, 
vascularised cell clusters, within relatively cool and thermally homogenous healthy 
tissues. Situations characterised by a focal heat source within a relatively cool and 
thermally homogeneous surrounding material are ideally suited to TIRI-based HSDD. 
The main threats to the technical feasibility revolve around a potential discrimination 
failure mode (Figure 36), and the validity of the single bioheat transfer model across 
various anatomic locations. These technical challenges and possible solutions are 
discussed further below. 
 
 





The clinical impact potential of a robust TIRI-based tumour depth determination 
system stems from; the critical role of tumour depth in oncological prognosis, the 
invasiveness of current tumour depth determination techniques, and the huge global 
health burden of applicable cancers.  As a key factor in oncological prognosis, tumour 
depth has a major influence on important treatment decisions at several stages 
through a cancer patient’s care. Formerly known as ‘Breslow’s Depth’ in recognition of 
pathologist Alexander Breslow’s work to objectively translate tumour depth 
measurements into useful prognostic factors (Breslow, 1970), tumour depth is now a 
key foundation of the AJCC (American Joint Committee on Cancer) system for staging 
melanoma. 
Subsequent clinical trials have validated tumour depth as a continuous variable 
correlating with prognostic factor, being particularly useful in prediction of lymph 
node metastasis with deeper tumours more likely to have spread to the lymph nodes 
(Breslow, 1970; Buttner et al., 1995; Buzzaid et al, 1997; Balch et al., 2001, Rousseau et 
al., 2003). With tumour depths currently determined via highly invasive biopsies and 
time consuming costly pathology lab work, development of a non-invasive, rapid, 
inexpensive alternative is highly desirable. Critical to this development will be a 
solution to the potential failure mode illustrated in Figure 36. This potential failure 
mode surrounds the technique’s ability to distinguish between 
 
 
Figure 36. Possible Depth Determination Failure Mode - sources at different depths could project 





skin surface temperature distributions caused by ‘deep hot small’ sources and ‘shallow 
warm large’ sources. In this scenario, both heat sources could project identical 
temperature distributions on the skin’s surface, as seen by TIRI.  
In the current algorithm, accurate initial estimates of key parameters like 
source temperature and source depth provide some safeguard against this failure 
mode. More robust and physically valid protection against this failure mode may be 
achieved via empirical TIRI research surrounding an articifical heat source embedded 
within an artificial tissue phantom. Specifically, a program of TIRI research within a 
controlled environment surrounding a controllable and known heat source embedded 
within a tissue phantom of known heat transfer properties.   
This experimental setup will allow investigation of the sensitivity of the 
algorithm to the aforementioned initial parameter estimates. The fact that the code 
recovers source depths consistent with anatomic expectations (ranging from 1 to 3 
mm) for all ROI’s in all participants, despite surface temperatures being extremely 
similar for all ROI’s in all participants (S.D. for entire sample = 0.31, ranging from 
304.8K – 306.1K) suggests there is opportunity to improve the current implementation 
of the algorithm by reducing sensitivity to initial parameter estimates (Arthur & Khan, 
2013).  
Future implementations should strive to ensure that clinically obtained surface 
temperature distributions have significantly greater influence over final heat source 
depth results than operator determined initial parameter estimates. One way to 
facilitate the necessary technique improvements is to ensure that any  experimental 
tissue phantom hardware is MRI-compatible, enabling development of TIRI compatible 
thermometric MRI sequences. Although thermometric MRI is highly valuable as a 
standalone clinical modality/technique, empirical research that simultaneously 
combines TIRI and thermometric MRI could provide a validation modality for future 
TIRI research, and also reveal fundamental TIRI-MRI dynamics that could enable TIRI 
to support thermometric MRI research in turn. 
Although both modality-specific and multi-modality tissue phantoms are 
commercially available (e.g. medimgsys), development of a tissue phantom that is 





MRI context would be a valuable research contribution in itself. Although high fidelity 
representation of heat transfer properties is crucial for any thermal tissue phantom, 
the HSDD findings in chapter 6 suggest that investing research efforts in maximising 
the precision of a phantom’s heat transfer properties would be less valuable than work 
to more accurately characterise the general thermodynamics required for clinical 
decision support. Specifically, despite the significant differences in the fat content of 
the 3 tibial ROI’s investigated, the lack of variation in the range of human tissue 
thermal conductivity values reported in the literature (~ 0.45 - 0.55) suggests there is 
little performance to be gained from efforts to use ROI-specific thermal conductivity 
values in future implementations of the algorithm. 
In summary, this work has demonstrated that TIRI can be extremely useful in 
determining the depth of focal heat sources within human tissues, and it is 
recommended that future research efforts be specifically directed toward application 
in tumour depth determination. Tumour depth determination stands out as an ideal 
application to work towards in terms of both technical feasibility (tumours occur as 
focal heat sources) and potential for positive public health impact (focal cancers 
currently impose a huge global disease burden).  
Specifically, it is recommended that the next steps in research and development 
focus on robustness of the technique to common failure modes, via integrated 
empirical TIRI-MRI studies on tissue phantoms which are thermodynamically 
representative in both modalities. As we move into a world where initiatives like 
ObamaCare are placing extreme and necessary pressure on the medical device 
industry to deliver both diagnostic and therapeutic technologies that take cost out of 
the health care system, low-cost high-utility technologies like TIRI will receive more 









1.28 Emissivity in Clinical TIRI 
Emissivity ‘Ɛ’ converts measurements of energy radiated from a particular material ‘j’ 
(Wm-2) into measurements of that particular materials temperature based on the 
energy that would be radiated from an ‘blackbody’ material under the same regime of 
temperature, waveband and viewing conditions ( 0.1 ). As the definition implies, 
emissivity is highly regime-dependent, and this thesis work showed that human skin 
emissivity varies significantly across clinically-relevant regimes of wavelength and 
skin type (Figure 37). This finding motivates change of practice toward use of regime-
specific emissivities in applications where absolute temperature accuracy is critical 
(Arthur & Khan, 2013).  
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An important next step will be to quantify the magnitude of the risk that emissivity 
variation poses in context of some specific TIRI-supported clinical decisions. For 
example, in context of a TIRI-guided thermal ablation procedure, use of the nominal  
 
 





0.98 emissivity value when the tumour’s actual emissivity is 0.83 (the lowest value 
calculated during the Flir study), translates to a 16% error in temperature readings 
displayed to the surgeon. In the case of a 50°C target temperature, as is typical in 
thermal ablation of cancerous tumours, a 16% thermometry error equates to ±8°C. The 
emissivity error would then lead to the kill zone being raised to 58°C, killing an 
unnecessarily large area of healthy tissue surrounding the tumour. Conversely, an 8°C 
underestimate in emissivity would cause the surgeon to prematurely cease heat 
application once the tumour had actually only reached 42°C, failing to induce thermal 
cell death through the entirety of the tumour mass, causing the procedure to fail, and 
leaving the patient at serious risk. 
 Thermal ablation is just one example among many clinical applications in which 
the physiological significance of a specific absolute temperature makes emissivity 
critical, such as; cancer diagnostics, intraoperative haemodynamic monitoring, and 
affective computing (Çetingül & Herman, 2010c; de Weerd, 2010b; M. Khan et al., 
2006; Ng & Acharya, 2009). Accordingly, a recommended next step for research is 
investigation of the impact of realistic emissivity errors on the clinical decision being 
supported by TIRI in other promising clinical applications outside of thermal ablation. 
The experiments to measure the impact of emissivity errors upon the clinical decision 
being supported by TIRI should be conducted in realistic context of regime (waveband 
& ROI), disease state, clinical image acquisition conditions, data-processing 
circumstances, and physician decision making. 
 It is also recommended that research be carried out to investigate the relative 
merits of different techniques for measurement of emissivity in-situ. As mentioned in 
chapter 7, the two main classes of technique are based upon direct reflectance 
measurement and direct blackbody comparison. Although reflectance-based 
techniques are non-contact and do not require a costly blackbody source, real-world 
considerations like the shift from Lambertian (matte / diffuse) to specular (shiny) 
reflectance with perspiration may compromise their reliability. Consideration of the 
relative merits of each technique should include the practical ease with which 





 In summary, recommended next steps with regard to the treatment and use of 
emissivity in clinical TIRI revolve around two questions; how significantly will 
emissivity errors impact the clinical decisions being supported under realistic 
conditions, and, how should in-situ emissivity be practically measured and integrated 
into clinical TIRI data. To ensure that in-situ emissivity measurement is not redundant, 
this research should be accompanied by quantification of uncertainty in absolute 
temperature measurement via TIRI due to all sources of uncertainty found in the 
practical clinical setting. 
























1.29 Overall Recommendations 
This program of research work investigated clinical applications of thermal infrared 
imaging, and produced interesting findings concerning clinical TIRI protocols, 
emissivity of human tissues, and heat source depth determination. First and foremost, 
it is recommended that future clinical TIRI research programs invest significant effort 
into developing and adhering to data acquisition and processing protocols, in the 
manner described in this thesis. Protocols should be designed with facilitation and 
optimisation of the entire process flow in mind, from initial clinical image acquisition 
through to data processing and the ultimate diagnostic decision being supported by 
the TIRI data. Only in the presence of such protocols can we properly evaluate TIRI’s 
potential usefulness in any given application. 
Clinical TIRI has its greatest potential in quantitative decision support 
applications, and as emissivity accuracy is the fundamental driver of performance in 
those applications, it is recommended that future research aims to better understand 
the nature and significance of emissivity in specific clinical TIRI applications. Although 
this work revealed emissivity variations with both waveband (MWIR/LWIR) and 
anatomic location, it is recommended that future emissivity research focusses on 
variations due to anatomic location, and constrain investigations to the LWIR. With 
significantly lower costs and comparable performance, it seems inevitable that LWIR 
systems will dominate the future of clinical TIRI. 
Finally, it is recommended that future research be strictly constrained to 
applications that have realistic promise of being useful in a real world clinical setting. 
Heat source depth determination is a great example of such an application, having 
significant significant PTRS (probability of technical and regulatory success), and real 
potential to improve clinical outcomes for large numbers of patients requiring 
important services like malignancy staging, metastasis prediction, resection guidance, 
tumour control monitoring and general prognostics. Similarly, osseous stress injury 
management exemplifies another class of appropriate clinical TIRI research, based 







With a global trend toward value-based healthcare exemplified by the introduction of 
the affordable care act (ObamaCare), the biomedical engineering community will face 
increasing pressure to prioritise technology affordability, both in diagnostics and 
therapeutics. Accordingly, TIRI will be among the low cost, simple to operate 
technologies deservedly receiving increasing research and development funding and 
attention as time goes on. 
 
 
 
  
 
  
 
